| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L DCAF6 MAML1 PEX14 DAXX BCL9 PHF2 KMT2C SQSTM1 TLE7 IRF2BPL NOTCH1 ZNF541 MRTFA KAT5 TCF20 CREBBP RALY KAT7 TLE4 TLE6 MYOCD SPEN HCFC1 | 1.27e-06 | 562 | 278 | 24 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L DCAF6 SEPTIN9 RIPK2 MAML1 PEX14 DAXX BCL9 PHF2 KMT2C MAVS AP1G1 SQSTM1 TRIM55 TLE7 IRF2BPL BAG6 NOTCH1 ZNF541 MRTFA SHANK1 DHX16 KAT5 TCF20 E2F1 CREBBP AKAP12 RALY KAT7 RGS14 TIRAP TLE4 MDC1 TLE6 MYOCD SPEN HCFC1 | 6.71e-05 | 1356 | 278 | 37 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L DCAF6 RIPK2 MAML1 PEX14 DAXX BCL9 PHF2 KMT2C MAVS AP1G1 SQSTM1 TRIM55 TLE7 IRF2BPL NOTCH1 ZNF541 MRTFA SHANK1 KAT5 TCF20 CREBBP AKAP12 RALY KAT7 RGS14 TIRAP TLE4 MDC1 TLE6 MYOCD SPEN HCFC1 | 7.84e-05 | 1160 | 278 | 33 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L DCAF6 MAML1 DAXX BCL9 PHF2 KMT2C NOTCH1 MRTFA KAT5 TCF20 CREBBP MYOCD HCFC1 | 9.58e-05 | 303 | 278 | 14 | GO:0003713 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 TBC1D9B PSD EPS8L1 DENND1C GMIP FARP2 ARHGAP25 SESN2 WAS TBC1D3L ARHGAP23 ARHGEF18 SIPA1 RGS14 ARFGAP2 TIAM1 ARHGEF26 | 2.86e-04 | 507 | 278 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 TBC1D9B PSD EPS8L1 DENND1C GMIP FARP2 ARHGAP25 SESN2 WAS TBC1D3L ARHGAP23 ARHGEF18 SIPA1 RGS14 ARFGAP2 TIAM1 ARHGEF26 | 2.86e-04 | 507 | 278 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | chromatin binding | CHAF1B EED BRIP1 TRIM66 TNRC18 EHMT2 TASOR DDX11L8 CRAMP1 NOTCH1 BAHCC1 KAT5 RARG GPER1 MLLT10 CREBBP PHC1 KAT7 YBX2 ASXL3 TLE4 PRDM15 HCFC1 | 2.89e-04 | 739 | 278 | 23 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA3 MAGEA6 HDAC11 STK36 HIF1A EED DAXX BPTF EHMT2 BSN KAT5 RARG PCLO E2F1 TACC2 CREBBP TLE4 CTDP1 LRP2 MYOCD SPEN HCFC1 TP53BP2 | 3.76e-04 | 753 | 278 | 23 | GO:0008134 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MAGEA3 MAGEA6 ZHX3 ZNF536 HIF1A EED RSF1 PEX14 DAXX MAGEB6 BCL7A RREB1 OTUD7B TRIM66 BPTF ZNF469 SALL2 EHMT2 SQSTM1 TLE7 IRF2BPL MAGEC1 SPINDOC TASOR NOTCH1 ZNF541 FOXM1 CUX2 ZBTB33 KAT5 RARG FOSB SOX30 E2F1 CREBBP PHC1 RALY LHX1 TLE4 TLE6 MYOCD HDAC10 SPEN HCFC1 | 9.61e-08 | 1413 | 273 | 44 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MAGEA3 MAGEA6 ZHX3 ZNF536 HIF1A EED RSF1 PEX14 DAXX MAGEB6 BCL7A RREB1 OTUD7B TRIM66 BPTF ZNF469 SALL2 EHMT2 SQSTM1 TLE7 IRF2BPL MAGEC1 SPINDOC NOTCH1 ZNF541 FOXM1 CUX2 ZBTB33 KAT5 RARG FOSB SOX30 E2F1 CREBBP PHC1 RALY LHX1 TLE4 TLE6 MYOCD HDAC10 SPEN HCFC1 | 1.97e-07 | 1399 | 273 | 43 | GO:0045892 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | MAG ARHGAP32 HIF1A CUL7 TTBK1 CX3CL1 GOLGA2 NOTCH1 CUX2 GPER1 E2F1 RGS14 TIAM1 ZNF335 NCAN LRP2 TLE6 SPEN NIN | 2.84e-07 | 354 | 273 | 19 | GO:0050769 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L HIF1A DCAF6 ZNF142 HIVEP2 RIPK2 MAML1 DAXX POGZ RREB1 BCL9 LILRB1 BPTF KMT2C SALL2 MAVS SQSTM1 PLAGL2 IRF2BPL CX3CL1 NOTCH1 MRTFA FOXM1 KAT5 RARG WAS TCF20 GPER1 FOSB SOX30 E2F1 DUX4 MLLT10 CREBBP KAT7 ASXL3 RFXANK ZNF335 MDC1 MYOCD PRDM15 HCFC1 | 4.40e-07 | 1390 | 273 | 42 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MAGEA3 MAGEA6 ZHX3 ZNF536 HIF1A EED DAXX MAGEB6 RREB1 OTUD7B BPTF ZNF469 SALL2 EHMT2 SQSTM1 IRF2BPL MAGEC1 NOTCH1 FOXM1 CUX2 ZBTB33 KAT5 RARG FOSB SOX30 E2F1 CREBBP RALY TLE4 TLE6 MYOCD HDAC10 SPEN HCFC1 | 1.47e-06 | 1053 | 273 | 34 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | MAG ARHGAP32 HIF1A CUL7 TTBK1 CX3CL1 GOLGA2 NOTCH1 CUX2 GPER1 E2F1 RGS14 TIAM1 ZNF335 NCAN LRP2 TLE6 SPEN NIN | 3.39e-06 | 418 | 273 | 19 | GO:0051962 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | MAG ARHGAP32 HIF1A RIPK2 CUL7 TTBK1 CX3CL1 GOLGA2 NOTCH1 CUX2 KAT5 GPER1 TMPRSS12 E2F1 RGS14 TIAM1 ZNF335 NCAN LRP2 TLE6 SPEN NIN | 2.51e-05 | 614 | 273 | 22 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MAG ARHGAP32 HIF1A CUL7 TTBK1 CX3CL1 GOLGA2 NOTCH1 CUX2 GPER1 E2F1 RGS14 TIAM1 ZNF335 NCAN LRP2 TLE6 SPEN NIN | 6.14e-05 | 515 | 273 | 19 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 9.18e-05 | 80 | 273 | 7 | GO:2000179 | |
| Domain | ZF_PHD_2 | 8.77e-06 | 95 | 267 | 9 | PS50016 | |
| Domain | Znf_FYVE_PHD | RSF1 PHF2 TRIM66 BPTF KMT2C ANKIB1 BSN TCF20 PCLO DIDO1 MLLT10 | 8.83e-06 | 147 | 267 | 11 | IPR011011 |
| Domain | ZF_PHD_1 | 9.55e-06 | 96 | 267 | 9 | PS01359 | |
| Domain | Ank | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 2.59e-05 | 228 | 267 | 13 | PF00023 |
| Domain | GAE | 2.83e-05 | 5 | 267 | 3 | PS50180 | |
| Domain | PHD | 4.08e-05 | 89 | 267 | 8 | SM00249 | |
| Domain | Znf_PHD | 4.79e-05 | 91 | 267 | 8 | IPR001965 | |
| Domain | - | 5.60e-05 | 6 | 267 | 3 | 2.60.40.1230 | |
| Domain | Clathrin_g-adaptin_app | 5.60e-05 | 6 | 267 | 3 | IPR008153 | |
| Domain | - | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 6.18e-05 | 248 | 267 | 13 | 1.25.40.20 |
| Domain | Ank_2 | CTTNBP2 EHMT2 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 6.51e-05 | 215 | 267 | 12 | PF12796 |
| Domain | ANK | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 6.99e-05 | 251 | 267 | 13 | SM00248 |
| Domain | ANK_REPEAT | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 7.57e-05 | 253 | 267 | 13 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 7.88e-05 | 254 | 267 | 13 | IPR020683 |
| Domain | ANK_REP_REGION | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 7.88e-05 | 254 | 267 | 13 | PS50297 |
| Domain | PHD | 9.77e-05 | 75 | 267 | 7 | PF00628 | |
| Domain | Ankyrin_rpt | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 1.08e-04 | 262 | 267 | 13 | IPR002110 |
| Domain | Znf_PHD-finger | 1.36e-04 | 79 | 267 | 7 | IPR019787 | |
| Domain | WH2_dom | 2.02e-04 | 21 | 267 | 4 | IPR003124 | |
| Domain | BCL9 | 2.04e-04 | 2 | 267 | 2 | PF11502 | |
| Domain | Cezanne-2 | 2.04e-04 | 2 | 267 | 2 | IPR033477 | |
| Domain | Bcl-9 | 2.04e-04 | 2 | 267 | 2 | IPR015668 | |
| Domain | BCL9_beta-catenin-bd_dom | 2.04e-04 | 2 | 267 | 2 | IPR024670 | |
| Domain | MAGEA3/MAGEA6 | 2.04e-04 | 2 | 267 | 2 | IPR030097 | |
| Domain | Znf_piccolo | 2.04e-04 | 2 | 267 | 2 | IPR008899 | |
| Domain | zf-piccolo | 2.04e-04 | 2 | 267 | 2 | PF05715 | |
| Domain | Alpha_adaptinC2 | 2.28e-04 | 9 | 267 | 3 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.28e-04 | 9 | 267 | 3 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.28e-04 | 9 | 267 | 3 | SM00809 | |
| Domain | UBA-like | 3.02e-04 | 64 | 267 | 6 | IPR009060 | |
| Domain | Zinc_finger_PHD-type_CS | 3.29e-04 | 65 | 267 | 6 | IPR019786 | |
| Domain | WH2 | 3.46e-04 | 24 | 267 | 4 | PS51082 | |
| Domain | Coatomer/clathrin_app_Ig-like | 5.78e-04 | 12 | 267 | 3 | IPR013041 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.51e-06 | 48 | 182 | 7 | M611 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.62e-05 | 28 | 182 | 5 | M6177 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.34e-05 | 48 | 182 | 6 | M288 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.62e-05 | 74 | 182 | 7 | M616 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP32 GMIP FARP2 ARHGAP25 PLD2 WIPF2 WAS ARHGAP23 WHAMM ARHGEF18 AKAP12 ARFGAP2 TIAM1 SH3PXD2A CAVIN1 ARHGEF26 SPEN | 7.44e-05 | 450 | 182 | 17 | M27078 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP32 GMIP FARP2 ARHGAP25 PLD2 WIPF2 WAS ARHGAP23 ARHGEF18 TIAM1 | 1.38e-04 | 184 | 182 | 10 | M41809 |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.96e-04 | 23 | 182 | 4 | MM14954 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 STK36 TBC1D9B HIVEP2 INPPL1 PIEZO1 MAML1 C15orf39 BCL7A BCL9 STK11IP ABCA7 MPRIP KMT2C TNRC18 XPO6 SLC52A2 BCL2L13 CRAMP1 NOTCH1 PRRC2B BAHCC1 DGCR2 FAM193B RARG SZT2 MLLT10 KCNH3 C6orf132 AATK MROH6 ZNF335 KANK3 CTDP1 ANKRD34A HMGXB3 MAPKBP1 ESPL1 SPEN GGA1 HCFC1 TOP3A | 1.51e-16 | 1105 | 286 | 42 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | STK36 ARHGAP32 UBAP2 ACACB INPPL1 APC2 PEX14 LMTK3 BCL9 OTUD7B ZNF469 TNRC18 BNIP3L SQSTM1 IRF2BPL BSN NOTCH1 MRTFA CUX2 ARHGEF18 MLLT10 C6orf132 AATK UBQLN3 MDC1 SPEN TP53BP2 | 3.96e-16 | 430 | 286 | 27 | 35044719 |
| Pubmed | 9.12e-15 | 12 | 286 | 8 | 10433963 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 1.88e-14 | 8 | 286 | 7 | 17588759 | |
| Pubmed | 2.35e-14 | 13 | 286 | 8 | 17668377 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L ZNF536 HIVEP2 ACACB MAML1 C15orf39 POGZ BCL7A RREB1 BCL9 BPTF KMT2C TNRC18 EHMT2 PRRC2B BAHCC1 KAT5 TCF20 CREBBP ASXL3 TLE4 MDC1 SPEN | 2.66e-14 | 351 | 286 | 23 | 38297188 |
| Pubmed | 2.78e-13 | 10 | 286 | 7 | 17984056 | ||
| Pubmed | 3.89e-12 | 13 | 286 | 7 | 7739628 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 CHAF1B PDE4C BRIP1 SEPTIN9 DAXX POGZ RREB1 BCL9 OTUD7B BPTF XPO6 IRF2BPL BAG6 MRTFA FOXM1 DHX16 TCF20 DIDO1 SMTN STC2 TLE4 ZNF335 MDC1 CTDP1 EIF3G ESPL1 SPEN EPB41L2 | 1.45e-11 | 774 | 286 | 29 | 15302935 |
| Pubmed | CHAF1B ZNF536 DCAF6 PSD RSF1 POGZ CUL7 BCL7A RREB1 PLEKHN1 ABCA7 PHF2 TRIM66 BPTF ZNF469 SALL2 EHMT2 SQSTM1 ABHD8 PRRC2B BAHCC1 TOR1AIP2 ZBTB33 KAT5 ARHGAP23 SIPA1 CREBBP ARG2 RALY KAT7 C1orf226 LRP2 FMN2 CAVIN1 NIN | 1.46e-11 | 1116 | 286 | 35 | 31753913 | |
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 4.28e-11 | 17 | 286 | 7 | 11245978 | |
| Pubmed | BCL9L ZHX3 ARHGAP32 ZNF536 UBAP2 ACACB MAML1 C15orf39 POGZ CUL7 BCL7A RREB1 BCL9 MPRIP PHF2 BPTF RNF214 KMT2C SALL2 EHMT2 SQSTM1 IRF2BPL PRRC2B CNOT11 ZBTB33 KAT5 TCF20 DIDO1 E2F1 MLLT10 CREBBP LHX1 RFXANK TLE4 MDC1 LRP2 EIF3G SPEN HCFC1 | 5.74e-11 | 1429 | 286 | 39 | 35140242 | |
| Pubmed | ZHX3 HIF1A RBM26 POGZ PHF2 BPTF PLAGL2 DUX4L4 MRTFA FOXM1 CUX2 ZBTB33 TCF20 FOSB DUX4L9 DIDO1 E2F1 POLE4 DUX4L2 MLLT10 ZNF446 PHC1 KAT7 PPP1R10 ARFGAP2 ZSCAN5B HMGXB3 | 9.33e-10 | 808 | 286 | 27 | 20412781 | |
| Pubmed | ZHX3 ZNF536 HIF1A HIVEP2 ZNF185 POGZ KMT2C SALL2 SQSTM1 PLAGL2 FOXM1 CUX2 ZBTB33 RARG TCF20 DIDO1 E2F1 TACC2 MLLT10 CREBBP PHC1 LHX1 RNF146 HMGXB3 TOP3A | 1.37e-09 | 709 | 286 | 25 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 CHAF1B EED BRIP1 INCENP RSF1 DAXX POGZ RREB1 PHF2 BPTF EHMT2 DHX16 TCF20 DIDO1 PHC1 KAT7 PPP1R10 RFXANK MDC1 SPEN PRDM15 HCFC1 | 1.71e-09 | 608 | 286 | 23 | 36089195 |
| Pubmed | FAM114A1 CHCHD10 HIF1A GGA2 CTTNBP2 SEPTIN9 PIEZO1 BCL9 SNX19 RNF214 TNRC18 EHMT2 SLC52A2 WIPF2 BCL2L13 NOTCH1 PRRC2B COL5A1 FAM193B ARHGAP23 DIDO1 TACC2 DNAAF9 PHC1 COL18A1 SH3PXD2A CSNK1G3 RNF146 NCAN RBM5 ANKRD24 PRDM15 PRODH | 2.22e-09 | 1215 | 286 | 33 | 15146197 | |
| Pubmed | ZNF536 BRIP1 UBAP2 ERP44 RBM26 MAML1 MPDZ RREB1 FARP2 HAUS8 MAVS SQSTM1 CLPTM1 TASOR FKBP15 ZBTB33 TCF20 SHC4 ARHGEF18 RALY MDC1 RBM5 EIF3G ESPL1 HCFC1 | 2.68e-09 | 733 | 286 | 25 | 34672954 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HIF1A EED BRIP1 HIVEP2 MAML1 DAXX CSDE1 PHF2 EHMT2 PLAGL2 MRTFA FOXM1 ZBTB33 KAT5 TCF20 E2F1 MLLT10 CREBBP ZNF446 LHX1 RFXANK TLE6 MYOCD HMGXB3 HDAC10 SPEN HCFC1 | 5.33e-09 | 877 | 286 | 27 | 20211142 |
| Pubmed | STK36 ARHGAP32 TBC1D9B CTTNBP2 ERP44 CUL7 KIAA0753 FARP2 PHF2 TRIM66 TNRC18 TTBK1 IRF2BPL ARHGAP25 TASOR FAM193B ARHGAP23 COBLL1 ARHGEF18 ANKRD24 | 6.36e-09 | 493 | 286 | 20 | 15368895 | |
| Pubmed | BCL9L ZHX3 RBM26 MAML1 BCL7A BCL9 TNRC18 EHMT2 PRRC2B ZBTB33 TCF20 CREBBP TLE4 MDC1 HCFC1 | 7.79e-09 | 268 | 286 | 15 | 33640491 | |
| Pubmed | MAGI1 ARHGAP32 UBAP2 CTTNBP2 APC2 RIPK2 MPDZ LMTK3 BCL9 CCDC177 TMEM132B MPRIP EHMT2 BSN GOLGA2 PRRC2B SHANK1 FKBP15 TCF20 ARHGEF18 DIDO1 SIPA1 AKAP12 NCAN CTNND2 ARHGEF26 EPB41L2 TP53BP2 | 9.39e-09 | 963 | 286 | 28 | 28671696 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | GGA2 ACD SEPTIN9 INPPL1 RBM26 MAML1 C15orf39 DAXX POGZ GMIP FARP2 CSDE1 HAUS8 AP1G1 SQSTM1 PLD2 GOLGA2 MRTFA DHX16 FKBP15 CNOT11 KAT7 ARFGAP2 SHROOM1 C1orf198 MROH6 RNF146 SNAPC3 ESPL1 | 1.21e-08 | 1038 | 286 | 29 | 26673895 |
| Pubmed | GGA2 UBAP2 PIEZO1 MAML1 POGZ LRRC47 KMT2C MAST4 NRXN2 ANKIB1 PLAGL2 BSN CRAMP1 DGCR2 SZT2 DIDO1 MDC1 HMGXB3 ESPL1 NIN | 2.05e-08 | 529 | 286 | 20 | 14621295 | |
| Pubmed | CHAF1B INCENP RSF1 KIAA0753 LRRC47 PHF2 PHKB HAUS8 EHMT2 SQSTM1 BAG6 FOXM1 CNOT11 KAT5 CREBBP PHC1 KAT7 PPP1R10 SPEN PRDM15 TP53BP2 NIN | 2.49e-08 | 645 | 286 | 22 | 25281560 | |
| Pubmed | SEPTIN9 RSF1 RBM26 ADAR MAVS EHMT2 SQSTM1 BAG6 GOLGA2 MRTFA COBLL1 DIDO1 TACC2 KAT7 PPP1R10 CTDP1 SPEN HCFC1 EPB41L2 | 4.74e-08 | 503 | 286 | 19 | 16964243 | |
| Pubmed | ZNF536 ERP44 ACACB C15orf39 POGZ RREB1 SALL2 EHMT2 SQSTM1 TASOR MRTFA ZBTB33 TCF20 PHC1 TLE4 LRP2 TP53BP2 | 8.60e-08 | 418 | 286 | 17 | 34709266 | |
| Pubmed | BCL9L DAXX RILP ADAR MPRIP TNRC18 PLAGL2 IRF2BPL PRRC2B PLD4 CREBBP SLC49A4 HMGXB3 EIF3G TP53BP2 | 1.31e-07 | 332 | 286 | 15 | 37433992 | |
| Pubmed | UBAP2 RBM26 MPDZ POGZ ADAR MPRIP CSDE1 BPTF KMT2C PRRC2B ZBTB33 TCF20 DIDO1 CREBBP PPP1R10 MDC1 SPEN HCFC1 TP53BP2 | 1.84e-07 | 549 | 286 | 19 | 38280479 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 ARHGAP32 UBAP2 SEPTIN9 INPPL1 ZNF185 EPS8L1 MPRIP MAVS WIPF2 GOLGA2 NOTCH1 ARHGAP23 COBLL1 C6orf132 ARFGAP2 C1orf198 HCFC1 TP53BP2 | 2.84e-07 | 565 | 286 | 19 | 25468996 |
| Pubmed | ZHX3 ZNF536 SEPTIN9 POGZ SNX19 RNF157 CSDE1 TRIL PRRC2B DHX16 FKBP15 TCF20 TLE4 MAPKBP1 SPEN VPS13B | 3.27e-07 | 407 | 286 | 16 | 12693553 | |
| Pubmed | Notch signaling mediates hypoxia-induced tumor cell migration and invasion. | 5.50e-07 | 3 | 286 | 3 | 18427106 | |
| Pubmed | MAGI1 ARHGAP32 ZNF142 HIVEP2 DAXX POGZ CSDE1 KMT2C WIPF2 GOLGA2 SHANK1 WAS TCF20 COBLL1 CREBBP ANKRD24 EPB41L2 | 7.10e-07 | 486 | 286 | 17 | 20936779 | |
| Pubmed | MAGI1 ARHGAP32 ERP44 INPPL1 MPDZ PEX14 GMIP ADAR MPRIP FARP2 CSDE1 ARHGAP25 WIPF2 ZBTB33 ARHGAP23 ARHGEF18 PPP1R10 TIAM1 SH3PXD2A RBM5 CAVIN1 EIF3G ARHGEF26 EPB41L2 | 7.30e-07 | 916 | 286 | 24 | 32203420 | |
| Pubmed | 7.82e-07 | 157 | 286 | 10 | 30186101 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 UBAP2 ACACB SEPTIN9 RSF1 RBM26 PEX14 ADAR MPRIP CSDE1 MAVS TASOR PRRC2B FKBP15 FAM193B ZBTB33 DIDO1 TACC2 AKAP12 PPP1R10 EIF3G HCFC1 EPB41L2 TP53BP2 | 1.03e-06 | 934 | 286 | 24 | 33916271 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SEPTIN9 ZNF185 DAXX CSDE1 SALL2 MAVS FOXM1 ZBTB33 TACC2 CREBBP SMTN PPP1R10 C1orf198 EIF3G HCFC1 EPB41L2 | 1.03e-06 | 444 | 286 | 16 | 34795231 |
| Pubmed | 1.04e-06 | 41 | 286 | 6 | 8724849 | ||
| Pubmed | GGA2 ERP44 ACACB BCL9 CSDE1 HAUS8 SALL2 MAVS AP1G1 WIPF2 GOLGA2 PRRC2B DHX16 TOR1AIP2 AKAP12 RALY PPP1R10 COL18A1 ARFGAP2 C1orf198 STC2 TLE4 EIF3G GGA1 EPB41L2 | 1.13e-06 | 1007 | 286 | 25 | 34597346 | |
| Pubmed | ZHX3 CHAF1B EED INCENP RSF1 RBM26 ADAR CSDE1 BPTF EHMT2 IRF2BPL DHX16 FKBP15 KAT5 TCF20 DIDO1 POLE4 CREBBP RALY KAT7 PPP1R10 MDC1 CAVIN1 EIF3G HCFC1 | 1.28e-06 | 1014 | 286 | 25 | 32416067 | |
| Pubmed | 1.65e-06 | 69 | 286 | 7 | 32238831 | ||
| Pubmed | BCL9L CHAF1B EED RSF1 LRRC47 HAUS8 BPTF KMT2C EHMT2 TASOR BAG6 KAT7 PPP1R10 EIF3G SPEN HCFC1 | 2.09e-06 | 469 | 286 | 16 | 27634302 | |
| Pubmed | HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma. | 2.19e-06 | 4 | 286 | 3 | 30415904 | |
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 2.19e-06 | 4 | 286 | 3 | 38509386 | |
| Pubmed | 2.19e-06 | 4 | 286 | 3 | 17911620 | ||
| Pubmed | ZHX3 BRIP1 INCENP PEX14 ADAR BPTF AP1G1 IRF2BPL GOLGA2 MRTFA TCF20 DIDO1 SMTN RALY C1orf198 TP53BP2 | 2.27e-06 | 472 | 286 | 16 | 38943005 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ZHX3 CHAF1B KBTBD8 RSF1 DAXX POGZ PHF2 BPTF EHMT2 E2F1 MLLT10 PHC1 KAT7 C1orf226 MDC1 CAVIN1 EPB41L2 | 2.48e-06 | 533 | 286 | 17 | 30554943 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 ARHGAP32 HIVEP2 UBAP2 INPPL1 RIPK2 MPDZ KIAA0753 MPRIP HAUS8 MAST4 SQSTM1 TCF20 COBLL1 C6orf132 ARFGAP2 TIAM1 SH3PXD2A OTUD7A FMN2 EPB41L2 TP53BP2 | 3.21e-06 | 861 | 286 | 22 | 36931259 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF6 INCENP POGZ BCL7A MPRIP CSDE1 PHKB HAUS8 EHMT2 SQSTM1 AHSG GOLGA2 PRRC2B DHX16 CNOT11 TACC2 AKAP12 SMTN RALY PPP1R10 CAVIN1 EIF3G ESPL1 HCFC1 VPS13B TOP3A | 4.06e-06 | 1155 | 286 | 26 | 20360068 |
| Pubmed | VWA5B2 C15orf39 LMTK3 KMT2C ANKIB1 BSN CRAMP1 TCF20 DUX4 AKAP12 ANKRD34A | 4.15e-06 | 233 | 286 | 11 | 37704626 | |
| Pubmed | 4.20e-06 | 14 | 286 | 4 | 16452088 | ||
| Pubmed | ACACB DAXX ADAR MPRIP DNHD1 COBLL1 PCARE ZNF335 MDC1 CTDP1 VPS13B | 4.32e-06 | 234 | 286 | 11 | 36243803 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBM26 ADAR BPTF DHX16 ZBTB33 TCF20 DIDO1 RALY PPP1R10 MDC1 SPEN HCFC1 | 4.59e-06 | 283 | 286 | 12 | 30585729 |
| Pubmed | MAGI1 ERP44 SEPTIN9 INPPL1 RSF1 RBM26 KIAA0753 OTUD7B KMT2C TNRC18 IRF2BPL PRRC2B CNOT11 AKAP12 PHC1 PPP1R10 ZNF335 EIF3G PRDM15 | 5.25e-06 | 689 | 286 | 19 | 36543142 | |
| Pubmed | Binding partners for the COOH-terminal appendage domains of the GGAs and gamma-adaptin. | 5.44e-06 | 5 | 286 | 3 | 12808037 | |
| Pubmed | 5.44e-06 | 5 | 286 | 3 | 20063414 | ||
| Pubmed | Analysis of Gga null mice demonstrates a non-redundant role for mammalian GGA2 during development. | 5.44e-06 | 5 | 286 | 3 | 22291915 | |
| Pubmed | ZHX3 ARHGAP32 ZNF536 ZNF142 ACACB RSF1 MAML1 BCL9 BSN PRRC2B TOR1AIP2 FAT4 TCF20 HBEGF CREBBP ASXL3 CTNND2 SPEN | 6.84e-06 | 638 | 286 | 18 | 31182584 | |
| Pubmed | GGA2 ACACB INCENP MAML1 PEX14 OTUD7B MAVS EHMT2 SQSTM1 AHSG TASOR PRRC2B FAT4 ZBTB33 AKAP12 ARFGAP2 RBM5 SPEN GGA1 EPB41L2 | 8.16e-06 | 777 | 286 | 20 | 35844135 | |
| Pubmed | ARHGAP32 GGA2 INPPL1 RREB1 KIAA0753 HAUS8 PRRC2B CNOT11 ARFGAP2 C1orf198 NIN | 8.41e-06 | 251 | 286 | 11 | 29778605 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | INPPL1 MAML1 C15orf39 DAXX CUL7 MPRIP SALL2 SQSTM1 BSN GOLGA2 PRRC2B FOXM1 TACC2 CREBBP SPEN TOP3A NIN | 9.01e-06 | 588 | 286 | 17 | 38580884 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | CHAF1B ZNF536 RBM26 MAML1 POGZ CUL7 ADAR BPTF SALL2 NOTCH1 FOXM1 DHX16 ZBTB33 KAT5 FOSB CREBBP RALY TLE4 SPEN PRDM15 HCFC1 | 1.02e-05 | 857 | 286 | 21 | 25609649 |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | ARHGAP32 ERP44 MAML1 C15orf39 NOTCH1 PRRC2B ARHGAP23 CREBBP C6orf132 STC2 EIF3G TP53BP2 | 1.04e-05 | 307 | 286 | 12 | 37499664 |
| Pubmed | SEPTIN9 LRRC47 CSDE1 BPTF EHMT2 WIPF2 GOLGA2 DHX16 DIDO1 SIPA1 AKAP12 RALY SNCAIP | 1.04e-05 | 360 | 286 | 13 | 33111431 | |
| Pubmed | 1.08e-05 | 6 | 286 | 3 | 10814529 | ||
| Pubmed | 1.08e-05 | 6 | 286 | 3 | 14576433 | ||
| Pubmed | Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. | 1.08e-05 | 6 | 286 | 3 | 12215646 | |
| Pubmed | ERP44 KBTBD8 KIAA0753 PHKB KMT2C AP1G1 SQSTM1 TASOR MRTFA TOR1AIP2 ARHGEF18 DIDO1 TACC2 AKAP12 SMTN KAT7 COL18A1 CSNK1G3 TLE4 LRP2 FMN2 HMGXB3 ESPL1 VPS13B | 1.27e-05 | 1084 | 286 | 24 | 11544199 | |
| Pubmed | POGZ MPRIP KMT2C TASOR CRAMP1 BAHCC1 FOXM1 TCF20 FOSB PPP1R10 | 1.40e-05 | 217 | 286 | 10 | 34048709 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MAGI1 UBAP2 MAML1 C15orf39 RREB1 MPRIP LRRC47 HAUS8 RNF214 XPO6 CLPTM1 PRRC2B TOR1AIP2 FKBP15 CNOT11 COBLL1 PCARE CREBBP AKAP12 PPP1R10 TIAM1 SH3PXD2A ANKRD34A CAVIN1 GGA1 TP53BP2 INVS | 1.50e-05 | 1321 | 286 | 27 | 27173435 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | CHAF1B EED HIVEP2 SKIDA1 POGZ CUL7 RREB1 BPTF KMT2C EHMT2 SESN2 DIDO1 E2F1 PHC1 HCFC1 | 1.77e-05 | 495 | 286 | 15 | 27705803 |
| Pubmed | BCL9L STK36 CHAF1B EED AP1G1 EHMT2 TASOR GOLGA2 MRTFA FOXM1 FAT4 KAT5 DIDO1 CREBBP RALY LHX1 ARFGAP2 TNFRSF8 MDC1 | 1.85e-05 | 754 | 286 | 19 | 35906200 | |
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 1.88e-05 | 7 | 286 | 3 | 30765463 | |
| Pubmed | Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5 complex. | 1.88e-05 | 7 | 286 | 3 | 12505986 | |
| Pubmed | 1.92e-05 | 225 | 286 | 10 | 12168954 | ||
| Pubmed | BCL9L PIEZO1 RBM26 MAML1 MPDZ DAXX BCL7A MPRIP FARP2 CSDE1 PHF2 KMT2C AP1G1 EHMT2 SQSTM1 TASOR CNOT11 KAT5 WHAMM DIDO1 C6orf132 PPP1R10 COL18A1 MDC1 RBM5 EIF3G CTNND2 SPEN EPB41L2 | 1.94e-05 | 1497 | 286 | 29 | 31527615 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | HDAC11 EED DAXX BPTF KMT2C BNIP3L NRXN2 SQSTM1 BAG6 GOLGA2 ANKRD35 FAM193B KAT5 POLE4 APOC1 AKAP12 KAT7 SNCAIP RBM5 HMGXB3 EIF3G CTNND2 IGSF21 TP53BP2 | 2.28e-05 | 1124 | 286 | 24 | 21900206 |
| Pubmed | 2.54e-05 | 104 | 286 | 7 | 9205841 | ||
| Pubmed | RIPK2 STK11IP MAVS CLPTM1 IRF2BPL BAG6 PRRC2B CREBBP TXLNB TIRAP HCFC1 | 2.56e-05 | 283 | 286 | 11 | 21903422 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | MPDZ RREB1 PHF2 TRIM66 RNF214 TRIM55 COL5A1 TCF20 CTDP1 RBM5 SPEN | 2.56e-05 | 283 | 286 | 11 | 18854154 |
| Pubmed | 2.70e-05 | 105 | 286 | 7 | 9628581 | ||
| Pubmed | ZHX3 CHAF1B MAML1 POGZ SALL2 TASOR FOXM1 KAT5 DIDO1 KAT7 SPEN HCFC1 | 2.77e-05 | 339 | 286 | 12 | 30415952 | |
| Pubmed | ACACB BPTF SALL2 PLD2 BAG6 TCF20 PCLO DIDO1 PHC1 KAT7 MDC1 CAVIN1 SPEN | 2.83e-05 | 396 | 286 | 13 | 26687479 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZHX3 EED MAML1 C15orf39 POGZ RREB1 KMT2C TNRC18 BAHCC1 TCF20 PCLO CREBBP ARFGAP2 | 2.98e-05 | 398 | 286 | 13 | 35016035 |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 2.99e-05 | 8 | 286 | 3 | 28296634 | |
| Pubmed | MPDZ C15orf39 GMIP FARP2 CSDE1 AP1G1 ANKIB1 TASOR DDX11L8 GOLGA2 PRRC2B DHX16 ARHGAP23 DIDO1 ARFGAP2 HCFC1 TOP3A | 3.22e-05 | 650 | 286 | 17 | 38777146 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.64e-05 | 150 | 286 | 8 | 28242625 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | UBAP2 SEPTIN9 DAXX POGZ ADAR MPRIP CSDE1 HAUS8 RNF214 SQSTM1 PRRC2B CNOT11 AKAP12 PPP1R10 SH3PXD2A CAVIN1 ESPL1 SPEN | 3.65e-05 | 724 | 286 | 18 | 36232890 |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 3.65e-05 | 110 | 286 | 7 | 37219487 | |
| Pubmed | 4.37e-05 | 199 | 286 | 9 | 36688959 | ||
| Pubmed | Definition of the consensus motif recognized by gamma-adaptin ear domains. | 4.46e-05 | 9 | 286 | 3 | 14665628 | |
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 21144999 | ||
| Pubmed | 4.46e-05 | 9 | 286 | 3 | 26221039 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 HIF1A DCAF6 HIVEP2 SEPTIN9 PEX14 FARP2 CSDE1 PHF2 PHKB BPTF KMT2C TNRC18 ANKIB1 CRAMP1 COL5A1 PCDHGB1 ARHGEF18 CREBBP RALY COL18A1 SH3PXD2A RBM5 ANKRD24 ARHGEF26 PRDM15 VPS13B INVS | 4.56e-05 | 1489 | 286 | 28 | 28611215 |
| Pubmed | ZHX3 SEPTIN9 RBM26 MAML1 C15orf39 POGZ RREB1 BCL9 ADAR CSDE1 PHF2 BPTF KMT2C TNRC18 PLAGL2 BAG6 PRRC2B TCF20 DIDO1 CREBBP RBM5 SPEN HCFC1 | 4.86e-05 | 1103 | 286 | 23 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 BRIP1 UBAP2 INCENP SEPTIN9 RSF1 RBM26 POGZ RREB1 ADAR PHF2 BPTF TASOR ZBTB33 TCF20 DIDO1 PPP1R10 YBX2 MDC1 SPEN HCFC1 | 4.86e-05 | 954 | 286 | 21 | 36373674 |
| Pubmed | Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. | 5.68e-05 | 50 | 286 | 5 | 31699778 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | HDAC11 CHCHD10 EED EHMT2 NOTCH1 ANKRD35 RARG E2F1 POLE4 PHC1 LHX1 TLE4 HDAC10 | 5.69e-05 | 424 | 286 | 13 | 21731673 |
| Pubmed | BCL9L ZHX3 INCENP RSF1 MAML1 C15orf39 BCL9 BAG6 TCF20 PCLO CREBBP SMTN C1orf198 | 5.83e-05 | 425 | 286 | 13 | 24999758 | |
| Pubmed | 5.91e-05 | 257 | 286 | 10 | 30945288 | ||
| Pubmed | 6.04e-05 | 119 | 286 | 7 | 23508102 | ||
| Interaction | BAG2 interactions | VWA5B2 HDAC11 HIF1A EED UBAP2 C15orf39 CUL7 RREB1 KIAA0753 CSDE1 TRIM66 BPTF RNF214 SALL2 MAVS IRF2BPL PLD2 SPINDOC MRTFA FKBP15 TCF20 CREBBP PHC1 ARFGAP2 SHROOM1 TLE4 MDC1 ESPL1 SPEN VPS13B TP53BP2 | 4.90e-10 | 622 | 274 | 31 | int:BAG2 |
| Interaction | EGR2 interactions | BCL9L ZNF536 HIVEP2 MAML1 C15orf39 POGZ BCL7A RREB1 BCL9 KMT2C TNRC18 GOLGA2 PRRC2B BAHCC1 CREBBP HCFC1 | 1.66e-09 | 171 | 274 | 16 | int:EGR2 |
| Interaction | TOP3B interactions | VWA5B2 STK36 TBC1D9B HIVEP2 UBAP2 INPPL1 PIEZO1 MAML1 C15orf39 BCL7A BCL9 STK11IP ABCA7 MPRIP CSDE1 KMT2C TNRC18 XPO6 AHSG SLC52A2 BCL2L13 ADAMTSL4 CRAMP1 NOTCH1 PRRC2B BAHCC1 DGCR2 FAM193B CNOT11 RARG SZT2 MLLT10 KCNH3 C6orf132 AATK MROH6 ZNF335 KANK3 MDC1 CTDP1 ANKRD34A HMGXB3 MAPKBP1 ESPL1 SPEN GGA1 HCFC1 TOP3A | 1.18e-08 | 1470 | 274 | 48 | int:TOP3B |
| Interaction | GSC interactions | BCL9L ZNF536 C15orf39 RREB1 BCL9 KMT2C TNRC18 BAHCC1 CREBBP ASXL3 TLE4 | 2.70e-08 | 87 | 274 | 11 | int:GSC |
| Interaction | CRX interactions | BCL9L ZNF536 MAML1 C15orf39 POGZ RREB1 BCL9 KMT2C TNRC18 EHMT2 PRRC2B BAHCC1 KAT5 TCF20 SZT2 CREBBP SPEN | 7.86e-08 | 254 | 274 | 17 | int:CRX |
| Interaction | TBXT interactions | ZNF536 MAML1 POGZ BCL7A BCL9 KMT2C EHMT2 TCF20 CREBBP TLE4 SPEN | 5.35e-07 | 116 | 274 | 11 | int:TBXT |
| Interaction | TERF2IP interactions | ZHX3 CHAF1B ZNF536 EED BRIP1 ACD INCENP RSF1 EPS8L1 POGZ RREB1 BPTF SALL2 TASOR DHX16 TCF20 DIDO1 CREBBP PHC1 PPP1R10 MDC1 RBM5 SPEN HCFC1 | 6.06e-07 | 552 | 274 | 24 | int:TERF2IP |
| Interaction | PAX9 interactions | BCL9L ZNF536 MAML1 C15orf39 BCL7A BCL9 KMT2C EHMT2 PLAGL2 TCF20 TLE4 | 1.67e-06 | 130 | 274 | 11 | int:PAX9 |
| Interaction | FEV interactions | MAML1 C15orf39 POGZ BCL7A RREB1 BCL9 KMT2C EHMT2 PRRC2B TCF20 MLLT10 CREBBP TLE4 | 4.43e-06 | 203 | 274 | 13 | int:FEV |
| Interaction | ASF1A interactions | CHAF1B ZNF536 BRIP1 INCENP POGZ RREB1 PHF2 SALL2 TCF20 E2F1 ARFGAP2 MDC1 SPEN HCFC1 | 8.57e-06 | 249 | 274 | 14 | int:ASF1A |
| Interaction | H2BC21 interactions | EED INCENP RSF1 DAXX POGZ MAGEB6 CUL7 BCL7A RREB1 PHF2 BPTF EHMT2 SAGE1 BAHCC1 TCF20 PCLO DIDO1 MLLT10 CREBBP PHC1 KAT7 PPP1R10 MDC1 HCFC1 TOP3A | 1.05e-05 | 696 | 274 | 25 | int:H2BC21 |
| Interaction | PAX6 interactions | ZNF536 PDE4C RBM26 USP25 POGZ BCL7A RREB1 BCL9 STAC BPTF KMT2C EHMT2 PRRC2B CREBBP TLE4 HDAC10 EPB41L2 | 1.19e-05 | 366 | 274 | 17 | int:PAX6 |
| Interaction | AR interactions | BCL9L ZHX3 HIF1A DCAF6 EED INPPL1 RBM26 MAML1 DAXX BCL7A RREB1 BCL9 ADAR KMT2C TNRC18 EHMT2 SQSTM1 IRF2BPL BAG6 PRRC2B ZBTB33 KAT5 TCF20 SHC4 DIDO1 E2F1 CREBBP KAT7 TLE4 MDC1 HCFC1 | 1.45e-05 | 992 | 274 | 31 | int:AR |
| Interaction | SOX7 interactions | 1.57e-05 | 82 | 274 | 8 | int:SOX7 | |
| Interaction | H3C3 interactions | ZHX3 CHAF1B EED BRIP1 INCENP RSF1 DAXX POGZ RREB1 PHF2 BPTF EHMT2 TCF20 DIDO1 PHC1 KAT7 RFXANK MDC1 SPEN PRDM15 | 1.58e-05 | 495 | 274 | 20 | int:H3C3 |
| Interaction | HMGA1 interactions | STK36 HIF1A EED ACACB RSF1 POGZ CUL7 RNF214 TNRC18 RARG TCF20 PCLO CREBBP KAT7 MDC1 SPEN HCFC1 EPB41L2 | 1.89e-05 | 419 | 274 | 18 | int:HMGA1 |
| Interaction | USP7 interactions | ZNF536 HIF1A EED UBAP2 ACACB ACD ZNF185 SKIDA1 DAXX ADAR MPRIP NUTM1 TRIL MAVS TRIM55 KLHDC7A BSN BAG6 NOTCH1 FOXM1 DNHD1 ANKRD35 MPC1L KAT5 WAS TCF20 COBLL1 NTN3 PCARE CREBBP RALY SLC9A3 TNFRSF8 ZNF335 MDC1 CTDP1 VPS13B | 2.04e-05 | 1313 | 274 | 37 | int:USP7 |
| Interaction | TLX1 interactions | ZNF536 MAML1 POGZ BCL7A RREB1 BCL9 KMT2C EHMT2 TCF20 CREBBP TLE4 | 2.88e-05 | 175 | 274 | 11 | int:TLX1 |
| Interaction | FHL2 interactions | HIF1A ERP44 POGZ TNRC18 TRIM55 MRTFA BAHCC1 CNOT11 KAT5 SOX30 E2F1 CREBBP SNCAIP TNFRSF8 RBM5 CAVIN1 SPEN | 3.25e-05 | 396 | 274 | 17 | int:FHL2 |
| Interaction | SMG7 interactions | MAML1 BCL9 KIAA0753 CSDE1 TRIM66 RNF214 SALL2 SQSTM1 PRRC2B TCF20 MLLT10 CREBBP TLE4 RBM5 NIN | 3.39e-05 | 319 | 274 | 15 | int:SMG7 |
| Interaction | KDM3A interactions | 3.45e-05 | 67 | 274 | 7 | int:KDM3A | |
| Interaction | H3-3A interactions | ZHX3 CHAF1B EED BRIP1 INCENP RSF1 DAXX POGZ RREB1 PHF2 BPTF KMT2C EHMT2 DHX16 TCF20 FOSB DIDO1 CREBBP KAT7 PPP1R10 TIAM1 MDC1 SPEN PRDM15 HCFC1 | 3.55e-05 | 749 | 274 | 25 | int:H3-3A |
| Interaction | LHX2 interactions | BCL9L ARHGAP32 ZNF536 POGZ BCL7A RREB1 BCL9 PHF2 KMT2C EHMT2 MRTFA | 4.34e-05 | 183 | 274 | 11 | int:LHX2 |
| Interaction | H2BC8 interactions | ZHX3 CHAF1B EED INCENP RSF1 POGZ RREB1 PHF2 BPTF EHMT2 TASOR FOXM1 DHX16 KAT5 TCF20 DIDO1 PHC1 KAT7 MDC1 SPEN PRDM15 | 4.40e-05 | 576 | 274 | 21 | int:H2BC8 |
| Interaction | VASP interactions | MAGI1 HIF1A INPPL1 MPDZ XPO6 SQSTM1 MRTFA WAS COBLL1 PCARE C6orf132 C1orf198 FMN2 TP53BP2 | 5.40e-05 | 294 | 274 | 14 | int:VASP |
| Interaction | OTUD7B interactions | 5.51e-05 | 72 | 274 | 7 | int:OTUD7B | |
| Interaction | MEX3A interactions | BCL9L ERP44 DAXX RILP ADAR MPRIP TNRC18 PLAGL2 IRF2BPL PRRC2B PLD4 CREBBP SLC49A4 HMGXB3 EIF3G TP53BP2 | 7.89e-05 | 384 | 274 | 16 | int:MEX3A |
| Interaction | PCDHGB6 interactions | 8.36e-05 | 7 | 274 | 3 | int:PCDHGB6 | |
| Interaction | RNF214 interactions | 8.80e-05 | 104 | 274 | 8 | int:RNF214 | |
| Interaction | DUXB interactions | 8.80e-05 | 18 | 274 | 4 | int:DUXB | |
| Interaction | FLOT1 interactions | MAGI1 ARHGAP32 EED INCENP SEPTIN9 MPDZ GMIP CUL7 SQSTM1 NOTCH1 PCLO AKAP12 C1orf226 TIAM1 CSNK1G3 FMN2 EPB41L2 NIN | 9.58e-05 | 475 | 274 | 18 | int:FLOT1 |
| Interaction | UHRF2 interactions | CHAF1B EED RSF1 BPTF EHMT2 ZBTB33 KAT5 DIDO1 E2F1 SMTN HCFC1 | 9.67e-05 | 200 | 274 | 11 | int:UHRF2 |
| Interaction | NF1 interactions | MAGI1 BRIP1 DGCR2 KAT5 TIAM1 SH3PXD2A TIRAP CTDP1 ANKRD34A CAVIN1 VPS13B TOP3A | 1.08e-04 | 238 | 274 | 12 | int:NF1 |
| Interaction | FBXO38 interactions | 1.69e-04 | 145 | 274 | 9 | int:FBXO38 | |
| Interaction | TLX3 interactions | BCL9L HIF1A BRIP1 MAML1 C15orf39 POGZ BCL9 KMT2C EHMT2 TCF20 FOSB TLE4 TLE6 | 1.87e-04 | 291 | 274 | 13 | int:TLX3 |
| Cytoband | 4q35.2 | 1.47e-08 | 27 | 286 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 7.80e-07 | 117 | 286 | 8 | chr4q35 | |
| GeneFamily | Ankyrin repeat domain containing | CTTNBP2 EHMT2 ANKIB1 NOTCH1 SHANK1 ANKRD35 SNCAIP RFXANK KANK3 ANKRD34A ANKRD24 TP53BP2 INVS | 2.34e-06 | 242 | 195 | 13 | 403 |
| GeneFamily | PHD finger proteins | 5.35e-05 | 90 | 195 | 7 | 88 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 6.16e-05 | 92 | 195 | 7 | 521 | |
| GeneFamily | PDZ domain containing | 2.47e-04 | 152 | 195 | 8 | 1220 | |
| GeneFamily | Golgi associated, gamma adaptin ear containing, ARF binding proteins | 3.45e-04 | 3 | 195 | 2 | 1031 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | PSD PLEKHN1 MPRIP FARP2 ARHGAP25 ARHGAP23 ARHGEF18 TIAM1 ARHGEF26 | 4.08e-04 | 206 | 195 | 9 | 682 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.51e-04 | 17 | 195 | 3 | 486 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.91e-04 | 181 | 195 | 8 | 694 | |
| GeneFamily | MAGE family | 8.85e-04 | 40 | 195 | 4 | 1136 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.05e-03 | 50 | 195 | 4 | 721 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | HIF1A SLC36A1 TBC1D9B INCENP KBTBD8 RIPK2 C15orf39 RREB1 LILRB1 TNRC18 BNIP3L SQSTM1 CLPTM1 PLAGL2 SESN2 PLD2 ADAMTSL4 BAG6 PLD4 BAHCC1 SHANK1 CUX2 ZBTB33 KAT5 ARHGAP23 GPER1 HBEGF FOSB COBLL1 SMTN ARG2 CSF2RB SLC49A4 EPB41L2 | 6.54e-07 | 1250 | 281 | 34 | M41099 |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | CHCHD10 CUL7 RNF157 FOXRED2 NOTCH1 BAHCC1 TMEM176B HBEGF COBLL1 CSF2RB CTNND2 ESPL1 | 1.86e-06 | 200 | 281 | 12 | M304 |
| Coexpression | GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | CHAF1B ZNF142 TBC1D9B UBAP2 SEPTIN9 PLEKHN1 RNF157 CSDE1 COL5A1 SMTN HCFC1 | 1.15e-05 | 200 | 281 | 11 | M6537 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | SEPTIN9 BCL7A BCL9 MPRIP KMT2C CLPTM1 PLAGL2 TASOR NOTCH1 BAHCC1 DGCR2 FAT4 CNOT11 TCF20 CREBBP TIAM1 MYOCD | 1.35e-05 | 467 | 281 | 17 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | SEPTIN9 BCL7A BCL9 MPRIP KMT2C CLPTM1 PLAGL2 TASOR NOTCH1 BAHCC1 DGCR2 FAT4 CNOT11 TCF20 CREBBP TIAM1 MYOCD | 2.13e-05 | 484 | 281 | 17 | MM999 |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | VWA5B2 MAG BCL9L CHCHD10 SLC36A1 CTTNBP2 CDHR3 STK11IP RNF157 PHF2 NRXN2 EHMT2 BSN BAHCC1 GPER1 DIDO1 C1orf198 RELL2 ZNF335 KANK3 NCAN OTUD7A FMN2 CTNND2 GGA1 | 3.98e-05 | 954 | 281 | 25 | MM3689 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 4.43e-05 | 60 | 281 | 6 | M1401 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN | 5.49e-05 | 158 | 281 | 9 | M8993 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | 5.91e-05 | 198 | 281 | 10 | M4309 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 6.17e-05 | 199 | 281 | 10 | M7254 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | SLC36A1 RSF1 MAML1 RREB1 BCL9 SALL2 XPO6 AKAP12 RGS14 C1QTNF12 | 6.43e-05 | 200 | 281 | 10 | M5069 |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MAGI1 CTTNBP2 TRIL NRXN2 AHSG TMEM200C AKAP12 SMTN COL18A1 SNCAIP ENHO | 3.82e-08 | 191 | 280 | 11 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MAGI1 CTTNBP2 TRIL NRXN2 AHSG TMEM200C AKAP12 SMTN COL18A1 SNCAIP ENHO | 3.82e-08 | 191 | 280 | 11 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MAGI1 CTTNBP2 TRIL NRXN2 AHSG TMEM200C AKAP12 SMTN COL18A1 SNCAIP ENHO | 3.82e-08 | 191 | 280 | 11 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-07 | 145 | 280 | 9 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ZNF536 TRABD2B TMEM132B TMEM176B HBEGF SHC4 AKAP12 C1orf198 ARHGEF26 EPB41L2 | 5.14e-07 | 197 | 280 | 10 | b2f4d7c301c0b24003374923b31d6d058e40b213 |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 174 | 280 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | ZNF536 APC2 TMEM132B SYNPR TMEM176B SHC4 COL18A1 C1orf198 AATK | 1.81e-06 | 176 | 280 | 9 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-06 | 177 | 280 | 9 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.98e-06 | 178 | 280 | 9 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 179 | 280 | 9 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 183 | 280 | 9 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZNF536 KBTBD8 CFAP100 TMEM200C CUX2 COL18A1 AATK ENHO IGSF21 | 2.49e-06 | 183 | 280 | 9 | 8330c39184ce076e1f95fd3725b68af551d89db0 |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 184 | 280 | 9 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 184 | 280 | 9 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CHCHD10 TRIL KLHDC7A TMEM200C ENHO NCAN CTNND2 ARHGEF26 PRODH | 2.85e-06 | 186 | 280 | 9 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAGI1 C15orf39 NRXN2 TMEM200C AKAP12 SMTN COL18A1 SNCAIP ENHO | 2.85e-06 | 186 | 280 | 9 | 0de87109da9324c597fadf2eb782f0f158afe832 |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAGI1 C15orf39 NRXN2 TMEM200C AKAP12 SMTN COL18A1 SNCAIP ENHO | 2.85e-06 | 186 | 280 | 9 | f23f21781a758541f59c06efa7739d26a03fb478 |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWA5B2 CTTNBP2 RBM26 PRRC2B CACNA1D FOSB PCLO DNAAF9 SH3PXD2A | 3.11e-06 | 188 | 280 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | GGA2 KBTBD8 PPP1R14A MPRIP FARP2 ARHGAP25 COBLL1 SH3PXD2A NIN | 3.39e-06 | 190 | 280 | 9 | ed100e271aac82806f59e0c613ccda63f59100c1 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-06 | 193 | 280 | 9 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 196 | 280 | 9 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ZNF536 APC2 PPP1R14A TMEM132B SYNPR TMEM176B SHC4 AATK ARHGEF26 | 4.55e-06 | 197 | 280 | 9 | e239caae24f40564a24ad909754f5436f767ccdb |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | PPP1R14A PLD4 DNHD1 TBC1D3L TMEM176B APOC1 KCNH3 ENHO SH3PXD2A | 4.55e-06 | 197 | 280 | 9 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | PPP1R14A PLD4 DNHD1 TBC1D3L TMEM176B APOC1 KCNH3 ENHO SH3PXD2A | 4.55e-06 | 197 | 280 | 9 | 15b87fd3906d7388c271d30d0c64b1bcc490801c |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | PIEZO1 ABCA7 TRIL HBEGF C1orf198 AATK CAVIN1 CTNND2 ARHGEF26 | 4.94e-06 | 199 | 280 | 9 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.94e-06 | 199 | 280 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.94e-06 | 199 | 280 | 9 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.99e-06 | 157 | 280 | 8 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.01e-05 | 165 | 280 | 8 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 1.05e-05 | 166 | 280 | 8 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 168 | 280 | 8 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.20e-05 | 169 | 280 | 8 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-05 | 122 | 280 | 7 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.36e-05 | 172 | 280 | 8 | 200b2e63313b110b8ca59ee5b72c02cc8ed907cd | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 173 | 280 | 8 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 174 | 280 | 8 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 126 | 280 | 7 | de09142c12fd2ad6ecc3e7707015582f751eb426 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-05 | 177 | 280 | 8 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 178 | 280 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 1.96e-05 | 181 | 280 | 8 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 181 | 280 | 8 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 184 | 280 | 8 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.30e-05 | 185 | 280 | 8 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.36e-05 | 135 | 280 | 7 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 186 | 280 | 8 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 186 | 280 | 8 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-05 | 187 | 280 | 8 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.68e-05 | 189 | 280 | 8 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.68e-05 | 189 | 280 | 8 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 190 | 280 | 8 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.84e-05 | 139 | 280 | 7 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.89e-05 | 191 | 280 | 8 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.00e-05 | 192 | 280 | 8 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.00e-05 | 192 | 280 | 8 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 192 | 280 | 8 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 192 | 280 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 192 | 280 | 8 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | MNPs-Dendritic_Cells|MNPs / lung cells shred on cell class, cell subclass, sample id | 3.11e-05 | 193 | 280 | 8 | 0e6b8e179bfe1c6e93137c76c76a91c7782a4989 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-05 | 193 | 280 | 8 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 193 | 280 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAM114A1 TRABD2B PPP1R14A ADAMTSL4 COL5A1 OLFML2B AKAP12 STC2 | 3.35e-05 | 195 | 280 | 8 | d663d54a4bcc94e2c9b50ed931e2b2db4ca41373 |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-05 | 195 | 280 | 8 | 6524ee7bdc70bb5955dd6a6f134a8e6d8b5f2b39 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.35e-05 | 195 | 280 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.39e-05 | 97 | 280 | 6 | 0d68bf2dfb9c221375b70b055f735536afb18f65 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-05 | 196 | 280 | 8 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-05 | 196 | 280 | 8 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | FAM114A1 TRABD2B PPP1R14A TRIL CACNA1D COL5A1 OLFML2B AKAP12 | 3.60e-05 | 197 | 280 | 8 | e3053ef8f604b6892c21c03e12612b49d3d30f23 |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.60e-05 | 197 | 280 | 8 | 8736f1d446db3eb28a99997a9a683ded8e18e4c6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-05 | 197 | 280 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.60e-05 | 197 | 280 | 8 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-05 | 197 | 280 | 8 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-05 | 197 | 280 | 8 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-05 | 197 | 280 | 8 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-05 | 198 | 280 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-05 | 198 | 280 | 8 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | CHCHD10 C15orf39 LILRB1 PLAGL2 ADAMTSL4 PLD4 TMEM176B TNFRSF8 | 3.73e-05 | 198 | 280 | 8 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 3.87e-05 | 199 | 280 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.87e-05 | 199 | 280 | 8 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.87e-05 | 199 | 280 | 8 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 199 | 280 | 8 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.01e-05 | 200 | 280 | 8 | 9f21e4e0913d8ef95a3f771dff0abaad8fe1d9f2 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 149 | 280 | 7 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.43e-05 | 149 | 280 | 7 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.60e-05 | 32 | 280 | 4 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.60e-05 | 32 | 280 | 4 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.62e-05 | 150 | 280 | 7 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-05 | 151 | 280 | 7 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.69e-05 | 155 | 280 | 7 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 156 | 280 | 7 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 156 | 280 | 7 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.93e-05 | 156 | 280 | 7 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 158 | 280 | 7 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-05 | 158 | 280 | 7 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-05 | 158 | 280 | 7 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-05 | 158 | 280 | 7 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-05 | 158 | 280 | 7 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 159 | 280 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 159 | 280 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 161 | 280 | 7 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.23e-05 | 161 | 280 | 7 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | ZHX3 INCENP POGZ BCL9 GOLGA2 MRTFA APOC1 TDRD1 CTDP1 LRP2 HMGXB3 ZNF701 CAVIN1 MAPKBP1 | 1.74e-07 | 197 | 281 | 14 | 3572_DN |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | GGA2 C15orf39 EPS8L1 GMIP CUL7 MRTFA BAHCC1 COL5A1 E2F1 COL18A1 RBM5 GGA1 HCFC1 PRODH | 1.85e-07 | 198 | 281 | 14 | 7035_UP |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A | ZHX3 C15orf39 CUL7 SQSTM1 GOLGA2 MRTFA HBEGF SOX30 APOC1 TIAM1 ARHGEF26 TOP3A | 5.36e-06 | 193 | 281 | 12 | 7315_UP |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | SLC36A1 GGA2 HIVEP2 ACD BCL7A XPO6 SQSTM1 PLAGL2 PRRC2B E2F1 SMTN STC2 | 5.36e-06 | 193 | 281 | 12 | 1228_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | ZNF142 EPS8L1 BCL7A PHF2 BPTF KAT5 RARG COBLL1 DIDO1 CREBBP STC2 | 6.08e-06 | 163 | 281 | 11 | 7453_DN |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | TBC1D9B GGA2 ACACB C15orf39 FARP2 PHF2 PLAGL2 GOLGA2 MRTFA E2F1 ZNF701 HCFC1 | 6.61e-06 | 197 | 281 | 12 | 7276_DN |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | C15orf39 BCL9 PHKB FOXRED2 SALL2 DGCR2 RARG COBLL1 AKAP12 SMTN SNAPC3 CTNND2 | 6.61e-06 | 197 | 281 | 12 | 1015_DN |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | ZHX3 HDAC11 ACACB FARP2 MRTFA BAHCC1 CACNA1D COL5A1 GPER1 HBEGF ZNF446 MAPKBP1 | 6.61e-06 | 197 | 281 | 12 | 6105_DN |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | SEPTIN9 CUL7 MAST4 PLD2 DGCR2 GPER1 PCLO APOC1 CTDP1 CAVIN1 CTNND2 TOP3A | 6.61e-06 | 197 | 281 | 12 | 5453_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | ZHX3 INCENP PRRC2B MRTFA BAHCC1 E2F1 SMTN LRP2 HMGXB3 ZNF701 CAVIN1 SNAPC3 | 6.61e-06 | 197 | 281 | 12 | 3566_DN |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | GGA2 GOLGA2 KAT5 PCLO APOC1 MLLT10 TIAM1 RNF146 RBM5 SNAPC3 MAPKBP1 CTNND2 | 6.96e-06 | 198 | 281 | 12 | 5490_DN |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | INCENP MPDZ BCL7A SNX19 PHKB WIPF2 FKBP15 E2F1 APOC1 MLLT10 CAVIN1 EPB41L2 | 6.96e-06 | 198 | 281 | 12 | 1479_DN |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | ARHGAP32 CHAF1B ZNF142 GGA2 BCL7A SNX19 KIAA0753 GOLGA2 MLLT10 RBM5 HMGXB3 EPB41L2 | 7.33e-06 | 199 | 281 | 12 | 165_DN |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | PCDHA9 INPPL1 POGZ BCL9 KIAA0753 CLPTM1 PRRC2B CACNA1D PCLO LRP2 HCFC1 TOP3A | 7.33e-06 | 199 | 281 | 12 | 5513_DN |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | ARHGAP32 GGA2 CLPTM1 CACNA1D DGCR2 PCLO MLLT10 COL18A1 STC2 TLE4 CTNND2 INVS | 7.71e-06 | 200 | 281 | 12 | 5510_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | INPPL1 PHF2 BPTF TASOR RARG COBLL1 DIDO1 CREBBP STC2 RBM5 SPEN | 1.40e-05 | 178 | 281 | 11 | 1112_DN |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | EED HIVEP2 MPDZ EPS8L1 POGZ SALL2 E2F1 AKAP12 SMTN CTNND2 GGA1 | 2.22e-05 | 187 | 281 | 11 | 1656_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | BPTF XPO6 TASOR PRRC2B RARG SMTN RBM5 HMGXB3 ESPL1 HCFC1 TP53BP2 | 2.22e-05 | 187 | 281 | 11 | 4989_DN |
| Drug | semustine; Up 200; 100uM; PC3; HT_HG-U133A | MPDZ PHF2 SQSTM1 GOLGA2 NOTCH1 RARG HBEGF ZNF446 ARG2 TIAM1 GGA1 | 2.97e-05 | 193 | 281 | 11 | 7545_UP |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | STOML1 PRRC2B BAHCC1 DGCR2 GPER1 E2F1 MMP25 COL18A1 RGS14 CTDP1 HCFC1 | 2.97e-05 | 193 | 281 | 11 | 3262_UP |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MAML1 BAHCC1 DGCR2 GPER1 COBLL1 RGS14 RBM5 ARHGEF26 HCFC1 VPS13B TOP3A | 2.97e-05 | 193 | 281 | 11 | 3943_DN |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | MAGI1 CUL7 BCL7A PLD2 WAS MLLT10 SMTN CTDP1 LRP2 HMGXB3 MAPKBP1 | 3.12e-05 | 194 | 281 | 11 | 954_UP |
| Drug | 2-deoxy-D-glucose; Down 200; 10000uM; MCF7; HG-U133A | ZNF142 GMIP SNX19 STAC GPER1 SZT2 MMP25 RGS14 AATK RFXANK ZNF701 | 3.12e-05 | 194 | 281 | 11 | 344_DN |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | INCENP PRRC2B MRTFA BAHCC1 KAT5 LHX1 CAVIN1 SNAPC3 MAPKBP1 ESPL1 GGA1 | 3.27e-05 | 195 | 281 | 11 | 3559_DN |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | GGA2 BRIP1 ACACB C15orf39 TRIM66 MAST4 GPER1 E2F1 MLLT10 ARG2 HCFC1 | 3.27e-05 | 195 | 281 | 11 | 2122_DN |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | SEPTIN9 C15orf39 PEX14 CUL7 BCL9 FOXRED2 PLD2 GOLGA2 FAM193B ZNF335 HMGXB3 | 3.43e-05 | 196 | 281 | 11 | 7419_DN |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | EPS8L1 CUL7 BAHCC1 DGCR2 TNFRSF8 ZNF701 CAVIN1 MAPKBP1 GGA1 TOP3A PRODH | 3.43e-05 | 196 | 281 | 11 | 6846_DN |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | TBC1D9B EED INPPL1 MAML1 MPDZ EPS8L1 PHF2 PLD2 MRTFA SMTN ZNF701 | 3.43e-05 | 196 | 281 | 11 | 3272_DN |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | ERP44 C15orf39 BAHCC1 DGCR2 DIDO1 SIPA1 ZNF446 COL18A1 SH3PXD2A CAVIN1 HCFC1 | 3.43e-05 | 196 | 281 | 11 | 2884_UP |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A | MAGI1 ZHX3 EED HIVEP2 BCL7A DGCR2 RARG COBLL1 MLLT10 ZNF701 GGA1 | 3.59e-05 | 197 | 281 | 11 | 3549_DN |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | C15orf39 PEX14 POGZ PRRC2B CACNA1D RARG WAS ZNF335 SNAPC3 HCFC1 PRODH | 3.59e-05 | 197 | 281 | 11 | 5025_DN |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | ZNF142 SLC36A1 ERP44 SEPTIN9 POGZ SNX19 SALL2 FAM193B E2F1 ESPL1 EPB41L2 | 3.59e-05 | 197 | 281 | 11 | 1941_DN |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | TBC1D9B SEPTIN9 PHKB DGCR2 COL5A1 FKBP15 RARG MLLT10 ZNF335 SNAPC3 TOP3A | 3.59e-05 | 197 | 281 | 11 | 1048_UP |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | HDAC11 PDE4C PCDHA9 EPS8L1 BCL7A ABCA7 DIDO1 APOC1 AATK GGA1 TOP3A | 3.59e-05 | 197 | 281 | 11 | 4477_DN |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A | C15orf39 POGZ BCL9 KIAA0753 MAST4 NOTCH1 DGCR2 RARG WAS CAVIN1 EPB41L2 | 3.59e-05 | 197 | 281 | 11 | 7208_DN |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | ZHX3 GGA2 C15orf39 BCL7A BCL9 PRRC2B RARG WAS COBLL1 MLLT10 ARHGEF26 | 3.59e-05 | 197 | 281 | 11 | 1697_DN |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | GGA2 CUL7 SALL2 PLAGL2 GOLGA2 GPER1 SMTN CTDP1 SNAPC3 SPEN TOP3A | 3.76e-05 | 198 | 281 | 11 | 914_DN |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | SLC36A1 BCL7A TRIM66 GOLGA2 MRTFA CACNA1D RARG SMTN TLE4 HMGXB3 HCFC1 | 3.76e-05 | 198 | 281 | 11 | 7238_DN |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | SLC36A1 GGA2 SEPTIN9 EPS8L1 GMIP BCL9 SQSTM1 GOLGA2 TIAM1 ZNF701 INVS | 3.76e-05 | 198 | 281 | 11 | 7384_DN |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ZHX3 C15orf39 EPS8L1 BCL9 FOXRED2 WIPF2 WAS HBEGF COBLL1 TDRD1 SNAPC3 | 3.76e-05 | 198 | 281 | 11 | 5690_DN |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; HL60; HG-U133A | INPPL1 PIEZO1 BCL7A LILRB1 BAHCC1 DIDO1 MLLT10 ARG2 ZNF335 TOP3A EPB41L2 | 3.76e-05 | 198 | 281 | 11 | 1983_UP |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | ZHX3 PIEZO1 GMIP BCL9 PRRC2B DGCR2 ARHGEF18 DIDO1 AKAP12 TIAM1 CTNND2 | 3.76e-05 | 198 | 281 | 11 | 3434_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | SEPTIN9 MAML1 PEX14 GMIP BCL7A ARHGAP25 GOLGA2 E2F1 SIPA1 HMGXB3 ZNF701 | 3.76e-05 | 198 | 281 | 11 | 2364_DN |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | GMIP FARP2 MAST4 PRRC2B GPER1 E2F1 TACC2 AKAP12 RBM5 ZNF701 EPB41L2 | 3.76e-05 | 198 | 281 | 11 | 7018_UP |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A | CHAF1B INPPL1 BCL7A SALL2 CLPTM1 PRRC2B BAHCC1 FKBP15 SZT2 MLLT10 GGA1 | 3.76e-05 | 198 | 281 | 11 | 1710_UP |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | HDAC11 FARP2 MAST4 MRTFA BAHCC1 COBLL1 APOC1 ZNF446 ARG2 LRP2 ZNF701 | 3.76e-05 | 198 | 281 | 11 | 4838_DN |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | ZNF142 SLC36A1 TBC1D9B STAC MAST4 PRRC2B MRTFA KAT5 CTDP1 MAPKBP1 TP53BP2 | 3.94e-05 | 199 | 281 | 11 | 578_UP |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | HDAC11 PDE4C ABCA7 FARP2 PHKB MAST4 APOC1 CTDP1 CAVIN1 HCFC1 TOP3A | 4.12e-05 | 200 | 281 | 11 | 6970_UP |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; HL60; HT_HG-U133A | SLC36A1 C15orf39 PEX14 POGZ CUL7 CLPTM1 PRRC2B SIPA1 MMP25 GGA1 HCFC1 | 4.12e-05 | 200 | 281 | 11 | 1278_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | EPS8L1 CUL7 KIAA0753 PHF2 RARG DIDO1 CREBBP STC2 ZNF335 HCFC1 | 6.07e-05 | 173 | 281 | 10 | 5987_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.01e-05 | 176 | 281 | 10 | 1535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.01e-05 | 176 | 281 | 10 | 3312_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 8.07e-05 | 179 | 281 | 10 | 331_DN | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | HIVEP2 C15orf39 BCL7A BCL9 SALL2 CACNA1D APOC1 STC2 ESPL1 TOP3A | 9.70e-05 | 183 | 281 | 10 | 5530_DN |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | ARHGAP32 GGA2 ERP44 SEPTIN9 ABHD8 GPER1 HBEGF AKAP12 ARG2 ZNF335 | 9.70e-05 | 183 | 281 | 10 | 7059_UP |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | BRIP1 HIVEP2 MPDZ PEX14 BPTF STOML1 TASOR TACC2 ESPL1 VPS13B | 1.06e-04 | 185 | 281 | 10 | 4755_DN |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | TBC1D9B EED LILRB1 SQSTM1 STOML1 DGCR2 COL5A1 KAT5 RARG TDRD1 | 1.32e-04 | 190 | 281 | 10 | 4637_UP |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.38e-04 | 191 | 281 | 10 | 2499_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.38e-04 | 191 | 281 | 10 | 7379_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | MAGI1 GGA2 ABCA7 TRIM66 BNIP3L MAST4 PLD2 ZNF446 CTDP1 CAVIN1 | 1.44e-04 | 192 | 281 | 10 | 6958_UP |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.44e-04 | 192 | 281 | 10 | 7378_DN | |
| Drug | mycinose | 1.48e-04 | 9 | 281 | 3 | CID005460589 | |
| Drug | p-cymen-8-ol | 1.52e-04 | 2 | 281 | 2 | CID000014529 | |
| Drug | apiol | 1.52e-04 | 2 | 281 | 2 | CID000010659 | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | ACACB PEX14 BCL7A WIPF2 PRRC2B RARG E2F1 COL18A1 HCFC1 TOP3A | 1.57e-04 | 194 | 281 | 10 | 1211_DN |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A | 1.57e-04 | 194 | 281 | 10 | 1377_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.57e-04 | 194 | 281 | 10 | 1822_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 1.57e-04 | 194 | 281 | 10 | 2213_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | ARHGAP32 TBC1D9B GGA2 KIAA0753 GOLGA2 E2F1 MLLT10 RGS14 RBM5 ARHGEF26 | 1.57e-04 | 194 | 281 | 10 | 4602_DN |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | INCENP SQSTM1 STOML1 GOLGA2 DGCR2 KAT5 WAS COBLL1 APOC1 MAPKBP1 | 1.63e-04 | 195 | 281 | 10 | 7408_DN |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | C15orf39 BCL9 FARP2 COL5A1 HBEGF E2F1 APOC1 LHX1 CTDP1 CTNND2 | 1.63e-04 | 195 | 281 | 10 | 5667_DN |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | ARHGAP32 TBC1D9B GGA2 BCL9 PLAGL2 ABHD8 GOLGA2 SMTN ARG2 RBM5 | 1.63e-04 | 195 | 281 | 10 | 1207_DN |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | HDAC11 PDE4C PCDHA9 SEPTIN9 POGZ PHF2 MAST4 WIPF2 GOLGA2 TDRD1 | 1.63e-04 | 195 | 281 | 10 | 3254_DN |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | ARHGAP32 ACACB SEPTIN9 GMIP CUL7 ABHD8 COL5A1 ZNF446 COL18A1 CTDP1 | 1.63e-04 | 195 | 281 | 10 | 5117_DN |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | GGA2 C15orf39 EPS8L1 TRIM66 GOLGA2 RARG GPER1 TLE4 CTNND2 TOP3A | 1.63e-04 | 195 | 281 | 10 | 953_DN |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 1465_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 7226_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | SEPTIN9 CUL7 CLPTM1 ZBTB33 LHX1 RGS14 LRP2 HMGXB3 TOP3A PRODH | 1.70e-04 | 196 | 281 | 10 | 2236_DN |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 3248_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | ARHGAP32 TBC1D9B PLD2 MRTFA BAHCC1 E2F1 TACC2 APOC1 MLLT10 ARHGEF26 | 1.70e-04 | 196 | 281 | 10 | 6615_DN |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | 1.70e-04 | 196 | 281 | 10 | 960_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | ACACB BCL7A FOXRED2 SQSTM1 STOML1 MRTFA BAHCC1 COL18A1 TIAM1 HCFC1 | 1.70e-04 | 196 | 281 | 10 | 2086_UP |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | GGA2 BRIP1 EPS8L1 DGCR2 ZNF446 MMP25 TIAM1 RNF146 CTDP1 HMGXB3 | 1.70e-04 | 196 | 281 | 10 | 2628_DN |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | ZHX3 EPS8L1 AHSG COL5A1 FKBP15 APOC1 ZNF446 TIAM1 TNFRSF8 CTNND2 | 1.70e-04 | 196 | 281 | 10 | 3726_DN |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 4776_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | ZHX3 HIVEP2 SEPTIN9 PHKB SQSTM1 STOML1 PLD2 APOC1 TDRD1 TIAM1 | 1.70e-04 | 196 | 281 | 10 | 7333_DN |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A | FAM114A1 GGA2 ERP44 RIPK2 EPS8L1 KIAA0753 MRTFA MMP25 LRP2 HMGXB3 | 1.70e-04 | 196 | 281 | 10 | 2390_DN |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; PC3; HT_HG-U133A | TBC1D9B INCENP GMIP KIAA0753 SQSTM1 GOLGA2 DGCR2 HBEGF SIPA1 VPS13B | 1.70e-04 | 196 | 281 | 10 | 7141_DN |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | ZNF142 HIVEP2 SEPTIN9 MPDZ C15orf39 BCL7A BCL9 MAST4 APOC1 GGA1 | 1.70e-04 | 196 | 281 | 10 | 7429_DN |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | HDAC11 ACACB EPS8L1 MAST4 STOML1 BAHCC1 OLFML2B TIAM1 SNAPC3 GGA1 | 1.70e-04 | 196 | 281 | 10 | 7512_UP |
| Drug | staurosporine; Down 200; 0.01uM; SKMEL5; HG-U133A | CHAF1B EED ACD EPS8L1 FOXRED2 PLD2 CX3CL1 GOLGA2 HBEGF AKAP12 | 1.70e-04 | 196 | 281 | 10 | 508_DN |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ERP44 C15orf39 GOLGA2 BAHCC1 DGCR2 RARG WAS E2F1 SMTN ZNF701 | 1.70e-04 | 196 | 281 | 10 | 3517_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 4494_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 6591_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 1.70e-04 | 196 | 281 | 10 | 6602_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | HDAC11 MAST4 BAHCC1 RARG WAS ZNF446 ZNF701 MAPKBP1 HCFC1 VPS13B | 1.70e-04 | 196 | 281 | 10 | 3936_DN |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | PHKB WIPF2 BAHCC1 COBLL1 LRP2 HMGXB3 ZNF701 SNAPC3 ARHGEF26 EPB41L2 | 1.70e-04 | 196 | 281 | 10 | 2249_DN |
| Drug | Sp 1 (pharmaceutical) | HDAC11 HIF1A MAML1 POGZ LILRB1 FOXM1 DGCR2 COL5A1 ZBTB33 KAT5 TCF20 DIDO1 E2F1 KCNH3 KAT7 MDC1 HDAC10 HCFC1 | 1.73e-04 | 548 | 281 | 18 | CID000099040 |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | SLC36A1 TBC1D9B PEX14 EPS8L1 BCL9 CLPTM1 WIPF2 TIAM1 RBM5 INVS | 1.78e-04 | 197 | 281 | 10 | 5819_DN |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | TBC1D9B FOXRED2 COL5A1 RARG GPER1 COBLL1 APOC1 LRP2 RBM5 PRODH | 1.78e-04 | 197 | 281 | 10 | 5400_DN |
| Disease | triglycerides in very small VLDL measurement | 2.85e-06 | 68 | 268 | 7 | EFO_0022144 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | HGFAC ZHX3 ACACB BPTF ABCG5 TIMD4 COBLL1 APOC1 CSNK1G3 KANK3 NCAN | 4.84e-06 | 215 | 268 | 11 | EFO_0008317, EFO_0008591 |
| Disease | Malignant neoplasm of breast | HIF1A TBC1D9B BRIP1 APC2 KBTBD8 ADAR PHKB KLHDC7A PLD2 NOTCH1 ZNF541 FOXM1 RARG PCDHGB6 GPER1 E2F1 TACC2 AKAP12 STC2 ANKRD34A CAVIN1 SPEN GGA1 VPS13B TP53BP2 PRODH | 6.22e-06 | 1074 | 268 | 26 | C0006142 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | HGFAC ZHX3 ACACB BPTF ABCG5 TIMD4 COBLL1 APOC1 CSNK1G3 KANK3 NCAN | 8.81e-06 | 229 | 268 | 11 | EFO_0004639, EFO_0008317 |
| Disease | triglycerides in small VLDL measurement | 1.94e-05 | 61 | 268 | 6 | EFO_0022145 | |
| Disease | triglycerides in small LDL measurement | 2.80e-05 | 65 | 268 | 6 | EFO_0022323 | |
| Disease | very low density lipoprotein cholesterol measurement | HGFAC ZHX3 ACACB BPTF ABCG5 TIMD4 COBLL1 APOC1 CSNK1G3 KANK3 NCAN | 2.87e-05 | 260 | 268 | 11 | EFO_0008317 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.62e-05 | 220 | 268 | 10 | EFO_0004529, EFO_0008317 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.21e-05 | 224 | 268 | 10 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | HGFAC ACACB BPTF CLPTM1 TIMD4 COBLL1 APOC1 CSNK1G3 KANK3 NCAN | 4.21e-05 | 224 | 268 | 10 | EFO_0004574, EFO_0008317 |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | HGFAC ZHX3 ACACB CLPTM1 TIMD4 COBLL1 APOC1 CSNK1G3 KANK3 NCAN | 4.37e-05 | 225 | 268 | 10 | EFO_0008317, EFO_0010351 |
| Disease | phospholipids:total lipids ratio | 4.71e-05 | 227 | 268 | 10 | EFO_0020946 | |
| Disease | fatty acid measurement | HGFAC ACACB INCENP GMIP BPTF CLPTM1 KAT5 TIMD4 FAM13C COBLL1 APOC1 KANK3 NCAN PRODH | 5.14e-05 | 436 | 268 | 14 | EFO_0005110 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.92e-05 | 152 | 268 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | HGFAC PDE4C PSD ACACB FARP2 BPTF AP1G1 CLPTM1 ABCG5 TIMD4 COBLL1 APOC1 CSNK1G3 TIRAP RNF146 NCAN EIF3G | 1.34e-04 | 663 | 268 | 17 | EFO_0004615 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.46e-04 | 166 | 268 | 8 | EFO_0004530, EFO_0004611 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.59e-04 | 126 | 268 | 7 | EFO_0004611, EFO_0010351 | |
| Disease | neutrophil count | MAGI1 PCDHA9 HIVEP2 SEPTIN9 MAML1 POGZ RREB1 BCL9 ADAR ABCA7 OTUD7B FARP2 BNIP3L SQSTM1 ARHGAP25 WIPF2 BCL2L13 CUX2 TIMD4 ARHGAP23 OLFML2B CREBBP AKAP12 AATK RP1L1 ANKRD34A PRODH | 1.64e-04 | 1382 | 268 | 27 | EFO_0004833 |
| Disease | breast carcinoma | INCENP SKIDA1 PEX14 RREB1 OTUD7B TRIL TTBK1 ANKIB1 IRF2BPL ABHD8 KLHDC7A MRTFA BAHCC1 SHANK1 CUX2 TACC2 MLLT10 RALY YBX2 RNF146 CAVIN1 IGSF21 | 1.73e-04 | 1019 | 268 | 22 | EFO_0000305 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.75e-04 | 128 | 268 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.75e-04 | 128 | 268 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.75e-04 | 128 | 268 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.75e-04 | 128 | 268 | 7 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.75e-04 | 128 | 268 | 7 | C0007134 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.16e-04 | 60 | 268 | 5 | EFO_0021898 | |
| Disease | very low density lipoprotein particle size measurement | 2.22e-04 | 133 | 268 | 7 | EFO_0008594 | |
| Disease | Squamous cell carcinoma of esophagus | 2.35e-04 | 95 | 268 | 6 | C0279626 | |
| Disease | Intellectual Disability | ZNF142 HIVEP2 APC2 POGZ CSDE1 BPTF KMT2C NRXN2 CUX2 TCF20 COL18A1 ZNF335 LRP2 | 2.51e-04 | 447 | 268 | 13 | C3714756 |
| Disease | phospholipids in large VLDL measurement | 2.53e-04 | 62 | 268 | 5 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.53e-04 | 62 | 268 | 5 | EFO_0022339 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.53e-04 | 62 | 268 | 5 | EFO_0022263 | |
| Disease | C-reactive protein measurement | HGFAC CCDC60 ZNF536 CDHR3 PEX14 RREB1 ADAR FARP2 BPTF ZNF469 CLPTM1 PLD2 BSN BCL2L13 CUX2 KAT5 OLFML2B COBLL1 APOC1 MLLT10 MROH6 TLE4 RNF146 RP1L1 | 2.93e-04 | 1206 | 268 | 24 | EFO_0004458 |
| Disease | Bladder Neoplasm | 3.03e-04 | 140 | 268 | 7 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.17e-04 | 141 | 268 | 7 | C0005684 | |
| Disease | creatinine measurement | HGFAC CHAF1B HIF1A BRIP1 PEX14 RREB1 NRXN2 KLHDC7A BSN ABCG5 MRTFA CUX2 ARHGEF18 APOC1 ARG2 COL18A1 RGS14 LRP2 ARHGEF26 IGSF21 PRODH | 3.28e-04 | 995 | 268 | 21 | EFO_0004518 |
| Disease | Mammary Carcinoma, Human | HIF1A BRIP1 APC2 ADAR KLHDC7A NOTCH1 FOXM1 PCDHGB6 GPER1 E2F1 AKAP12 STC2 ANKRD34A TP53BP2 | 3.52e-04 | 525 | 268 | 14 | C4704874 |
| Disease | Mammary Neoplasms, Human | HIF1A BRIP1 APC2 ADAR KLHDC7A NOTCH1 FOXM1 PCDHGB6 GPER1 E2F1 AKAP12 STC2 ANKRD34A TP53BP2 | 3.52e-04 | 525 | 268 | 14 | C1257931 |
| Disease | Mammary Neoplasms | HIF1A BRIP1 APC2 ADAR KLHDC7A NOTCH1 FOXM1 PCDHGB6 GPER1 E2F1 AKAP12 STC2 ANKRD34A TP53BP2 | 3.66e-04 | 527 | 268 | 14 | C1458155 |
| Disease | triglyceride measurement, phospholipid measurement | 3.91e-04 | 146 | 268 | 7 | EFO_0004530, EFO_0004639 | |
| Disease | serum alanine aminotransferase measurement | HGFAC PDE4C BRIP1 PSD SEPTIN9 MPRIP OTUD7B BPTF NRXN2 BCL2L13 ABCG5 CUX2 COBLL1 PCLO APOC1 MMP25 NCAN RP1L1 NIN | 4.11e-04 | 869 | 268 | 19 | EFO_0004735 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.24e-04 | 148 | 268 | 7 | C0279702 | |
| Disease | Breast Carcinoma | HIF1A BRIP1 APC2 ADAR KLHDC7A NOTCH1 FOXM1 PCDHGB6 GPER1 E2F1 AKAP12 STC2 ANKRD34A TP53BP2 | 4.49e-04 | 538 | 268 | 14 | C0678222 |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 5.17e-04 | 110 | 268 | 6 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 5.17e-04 | 110 | 268 | 6 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 5.68e-04 | 42 | 268 | 4 | EFO_0022255 | |
| Disease | exercise test | 7.53e-04 | 20 | 268 | 3 | EFO_0004328 | |
| Disease | erythrocyte band 7 integral membrane protein measurement | 8.07e-04 | 5 | 268 | 2 | EFO_0801584 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | HGFAC RNF214 CLPTM1 ABCG5 COBLL1 APOC1 RNF146 NCAN RP1L1 MAPKBP1 | 9.40e-04 | 330 | 268 | 10 | EFO_0004529, EFO_0004612 |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 9.59e-04 | 274 | 268 | 9 | EFO_0004530, EFO_0004612 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.14e-03 | 86 | 268 | 5 | EFO_0008595, EFO_0020945 | |
| Disease | white matter integrity | 1.24e-03 | 130 | 268 | 6 | EFO_0004641 | |
| Disease | sexual dimorphism measurement | ZNF142 HIVEP2 FARP2 BPTF RNF214 CLPTM1 BSN TASOR WIPF2 FOXM1 KAT5 COBLL1 TMPRSS12 E2F1 APOC1 SIPA1 RALY ZNF335 KANK3 MAPKBP1 EPB41L2 | 1.26e-03 | 1106 | 268 | 21 | EFO_0021796 |
| Disease | Global developmental delay | 1.39e-03 | 133 | 268 | 6 | C0557874 | |
| Disease | HbA1c measurement | ACACB PIEZO1 ZNF185 RREB1 LRRC47 HAUS8 ARHGAP25 BSN ABCG5 CUX2 TIMD4 COBLL1 SOX30 APOC1 TOP3A | 1.41e-03 | 675 | 268 | 15 | EFO_0004541 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.46e-03 | 291 | 268 | 9 | EFO_0008317, EFO_0020946 | |
| Disease | mental development measurement | 1.47e-03 | 25 | 268 | 3 | EFO_0008230 | |
| Disease | triglycerides in medium VLDL measurement | 1.58e-03 | 55 | 268 | 4 | EFO_0022155 | |
| Disease | hair colour measurement | PIEZO1 KBTBD8 PEX14 ZNF469 CUX2 SHC4 AKAP12 RALY TLE4 SLC49A4 FMN2 C1QTNF12 ARHGEF26 EPB41L2 | 1.61e-03 | 615 | 268 | 14 | EFO_0007822 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.62e-03 | 239 | 268 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | linoleic acid measurement | 1.62e-03 | 186 | 268 | 7 | EFO_0006807 | |
| Disease | Heart valve disease | 1.65e-03 | 26 | 268 | 3 | C0018824 | |
| Disease | triglycerides in large VLDL measurement | 1.69e-03 | 56 | 268 | 4 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 1.69e-03 | 56 | 268 | 4 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 1.69e-03 | 56 | 268 | 4 | EFO_0022325 | |
| Disease | macula measurement | 1.77e-03 | 189 | 268 | 7 | EFO_0008375 | |
| Disease | hypertension, COVID-19 | 1.84e-03 | 27 | 268 | 3 | EFO_0000537, MONDO_0100096 | |
| Disease | neuroimaging measurement | VWA5B2 MAGI1 ZHX3 UBAP2 CTTNBP2 SKIDA1 RBM26 RREB1 OTUD7B ZNF469 MAST4 BAHCC1 SZT2 HBEGF TACC2 APOC1 MLLT10 COL18A1 SH3PXD2A TLE4 | 1.95e-03 | 1069 | 268 | 20 | EFO_0004346 |
| Disease | triglycerides in VLDL measurement | 2.05e-03 | 59 | 268 | 4 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 2.05e-03 | 59 | 268 | 4 | EFO_0022301 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.05e-03 | 59 | 268 | 4 | EFO_0022260 | |
| Disease | total lipids in VLDL measurement | 2.18e-03 | 60 | 268 | 4 | EFO_0022314 | |
| Disease | Frontotemporal Dementia With Motor Neuron Disease | 2.22e-03 | 8 | 268 | 2 | C3888102 | |
| Disease | Adenoid Cystic Carcinoma | 2.22e-03 | 100 | 268 | 5 | C0010606 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.24e-03 | 197 | 268 | 7 | EFO_0005680 | |
| Disease | free cholesterol in very large VLDL measurement | 2.31e-03 | 61 | 268 | 4 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 2.31e-03 | 61 | 268 | 4 | EFO_0022276 | |
| Disease | free androgen index | HGFAC ZHX3 SEPTIN9 RREB1 ADAR ZNF469 EHMT2 CACNA1D CUX2 COBLL1 | 2.37e-03 | 374 | 268 | 10 | EFO_0007005 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.44e-03 | 200 | 268 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 2.44e-03 | 200 | 268 | 7 | EFO_0000195 | |
| Disease | triglycerides in small HDL measurement | 2.46e-03 | 62 | 268 | 4 | EFO_0022158 | |
| Disease | triglycerides in medium LDL measurement | 2.46e-03 | 62 | 268 | 4 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.46e-03 | 62 | 268 | 4 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 2.46e-03 | 62 | 268 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.46e-03 | 62 | 268 | 4 | EFO_0022299 | |
| Disease | erythrocyte measurement | 2.54e-03 | 257 | 268 | 8 | EFO_0005047 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.60e-03 | 63 | 268 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.60e-03 | 63 | 268 | 4 | EFO_0022239 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.60e-03 | 63 | 268 | 4 | EFO_0022292 | |
| Disease | tyrosine measurement | 2.64e-03 | 104 | 268 | 5 | EFO_0005058 | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 2.76e-03 | 31 | 268 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | BMI-adjusted waist circumference, forced expiratory volume | 2.84e-03 | 9 | 268 | 2 | EFO_0004314, EFO_0007789 | |
| Disease | infection | 2.84e-03 | 9 | 268 | 2 | EFO_0000544 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.86e-03 | 106 | 268 | 5 | EFO_0008317, EFO_0008596 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.88e-03 | 206 | 268 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | cholesterol in large VLDL measurement | 2.92e-03 | 65 | 268 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.92e-03 | 65 | 268 | 4 | EFO_0022230 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.99e-03 | 264 | 268 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | bone density | CHAF1B TRABD2B CTTNBP2 EPS8L1 RREB1 ARHGAP25 TACC2 CSNK1G3 FMN2 ESPL1 | 3.08e-03 | 388 | 268 | 10 | EFO_0003923 |
| Disease | unipolar depression, bipolar disorder | 3.10e-03 | 156 | 268 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | remnant cholesterol measurement | 3.10e-03 | 108 | 268 | 5 | EFO_0010815 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTSDEFGQQPTGPTS | 246 | Q8TBG9 | |
| LPAGNSVSPPSAESN | 106 | Q9BXT4 | |
| ILPSDNSGQVSPPES | 226 | Q9BXK5 | |
| DPAGQETTAITNPSP | 56 | P58512 | |
| QAPTSSQELAGAPEP | 411 | Q9Y5B0 | |
| EAAGLDSSTAPAQPP | 1381 | Q9P281 | |
| QNTAPGALPPDTLAE | 1146 | Q6ZSZ5 | |
| DPPGPNVATTTVSDD | 111 | O75821 | |
| VDSLSESSPNSSPGP | 41 | Q6UWT2 | |
| QLPTPSSPDESENQA | 336 | P78540 | |
| ANGSPQTELPPTELS | 206 | Q6UY14 | |
| APEPSSAGAQAAEEP | 21 | Q6NZI2 | |
| SSTNVESSAEGAPPP | 416 | P46379 | |
| EPQRENASPAPGTTA | 966 | P46379 | |
| STEQRSPEQPPEGSS | 6 | Q02952 | |
| PALQPSQAAPAEGVS | 216 | P0CJ87 | |
| TRNPADGIPAPESSS | 4826 | Q6V0I7 | |
| GPESPSVSAQNSDTP | 326 | Q96DB2 | |
| PAPAQGTPDVSSALD | 21 | P02654 | |
| PPGTPLSQAAASIDN | 956 | Q92793 | |
| PGPSEEKTLQPSSQN | 461 | Q13112 | |
| PSSSDPDSAGQDPNI | 951 | Q9P2G1 | |
| NLESKSPAAPGQSPT | 111 | O75534 | |
| PPLSQDVPGRADTSQ | 566 | Q96KQ7 | |
| PPNATASASSREGLP | 41 | Q5T7M4 | |
| APATEPSGTQQPAPS | 166 | Q8N6H7 | |
| QPAPSTESSGLAQPE | 176 | Q8N6H7 | |
| PSPTANGLAANNDSP | 171 | Q96DR7 | |
| PDLASQASPSEPQAG | 256 | Q8N283 | |
| SFVPQSSVQPPEGDS | 521 | Q58WW2 | |
| NPEPQFQTEATGPSA | 626 | Q58WW2 | |
| IAGALQDSPSSQPSP | 4666 | Q96M86 | |
| PALQPSQAAPAEGVS | 216 | P0CJ89 | |
| QRPSPPSALTEDDSG | 271 | Q8TF21 | |
| LQGDEEPSAPPTSTQ | 371 | O60231 | |
| SPPERPSLATASQNG | 726 | O14529 | |
| EEPGALNSPATPTSN | 766 | Q8IV53 | |
| LPPAQSSSVGPAEAQ | 2381 | Q12830 | |
| SPSASALVQPPANTE | 1006 | Q53SF7 | |
| SLSQSQGDPLPPAHT | 436 | Q9UQB3 | |
| APAATTSNEPSGNNP | 146 | Q9UER7 | |
| QTNQPPSDIKPDGSS | 516 | Q13625 | |
| LPPPAAEGASSVQQT | 1691 | Q9C0F0 | |
| GQEPESALPDSSLSP | 251 | Q8IZY2 | |
| TPPNAVGPLESVESS | 16 | Q96I13 | |
| SAPSPRQSQESLPGA | 376 | Q69YU3 | |
| SVNPGSDEPPSVNTQ | 256 | Q8IWA6 | |
| GSSRPPAPQENTTSE | 251 | Q9UKM9 | |
| PAPQENTTSEAGLPQ | 256 | Q9UKM9 | |
| GPVPSSTIEPAEAQS | 641 | Q5T8P6 | |
| ASSDSTGKPRQPNPD | 791 | Q9Y5H5 | |
| SSQPGPHPNASSEDE | 426 | P13631 | |
| GPAPDSLQVSAQPAE | 71 | Q96NA2 | |
| PPGASIAQVSASDPD | 466 | Q9Y5F9 | |
| EPVSQAEATSTGEPP | 1031 | Q9ULD8 | |
| EPFPASDNSGETPQR | 46 | O00763 | |
| PSGPQPTSQANDLLD | 616 | O43747 | |
| QAPLAQPESPTASAG | 441 | Q6GQQ9 | |
| QPESPTASAGDEPRS | 446 | Q6GQQ9 | |
| SSNQDPPPAASDQGE | 1441 | P51610 | |
| SSNGLPPASPLGQSD | 151 | Q92585 | |
| PPSPDDVTVSNAGDT | 461 | Q9NPA2 | |
| PRTPTGNAPSSESDI | 126 | O95251 | |
| KDQPDGSSLSPAQSP | 211 | Q6WCQ1 | |
| SQSQPPAASSLREPG | 226 | Q6WCQ1 | |
| GEPSQADVQPLGPSS | 2436 | P46531 | |
| PPVANSSLPCGQDST | 3561 | Q8NEZ4 | |
| AESPDPPQSPQGASS | 56 | P43357 | |
| AESPDPPQSPQGASS | 56 | P43360 | |
| PTAPELQASASTDQP | 1491 | Q14676 | |
| PQESQGVSPTGSPDA | 61 | Q8N7X4 | |
| SQSPLQIPQSSPEGD | 76 | O60732 | |
| QIPQSSPEGDDTQSP | 81 | O60732 | |
| HSQSPLQSPESAPEG | 671 | O60732 | |
| GSSRNEETPAAPTPA | 381 | Q7Z434 | |
| PPAEAQAPDQTDSSG | 771 | Q96QZ7 | |
| NVTESPSFSAGDNPP | 541 | P20916 | |
| PALQPSQAAPAEGIS | 216 | Q9UBX2 | |
| KPAASSPETPSAGQQ | 416 | Q9NQS7 | |
| EAPQPEGPATSSSLQ | 71 | Q9UKP3 | |
| PGPVAISDVAPSASN | 221 | Q86T24 | |
| DPPATAAAATSPGSQ | 116 | P0DKB6 | |
| EDSAPQASPGPSKQQ | 236 | Q9P107 | |
| PSDGSTRQSSPEPNS | 501 | Q16665 | |
| AVSGQLPDPTTNPSA | 526 | Q8N1G4 | |
| PSETAPASVFPQNGA | 161 | Q92993 | |
| LSVQAPPEGDTDPST | 1371 | Q96Q04 | |
| SVQPEADTQGQPAPS | 366 | Q9UPA5 | |
| QEPSNGTAASEPRPL | 141 | Q9H425 | |
| GSQPPPAAESQSSLR | 46 | O43491 | |
| PALQPSQAAPAEGVS | 216 | P0CJ86 | |
| TTDNDSPGADVPTPS | 456 | Q12766 | |
| EGPPELNRQSPNSSS | 206 | Q9H1B7 | |
| PPAQQTGSEKPSSEQ | 371 | Q9Y6V0 | |
| PDPDQSLPASSNPGN | 21 | A0PG75 | |
| NPPGASIAQVSASDP | 461 | Q9Y5G3 | |
| PPGASIAQISASDPD | 466 | Q9Y5G2 | |
| VGNPSSSNQLPPAED | 186 | Q08493 | |
| PDSQGLSPAAAAPSQ | 236 | P39060 | |
| ADVSPGLPAAQAQPS | 336 | Q14999 | |
| DSAAPSPIPGADNLS | 306 | Q5T1M5 | |
| GSPNTADLPGSPVSN | 431 | Q9P2S2 | |
| GSDPSLSPDSQDPSQ | 136 | P48742 | |
| PGEQASPEQPSASVS | 341 | Q9UJY5 | |
| EAGPLAPSPSSQNTP | 456 | Q9UJY4 | |
| SGTNTERPDTPTNTP | 46 | O75530 | |
| IVPETNPTSPAADGT | 4561 | P98164 | |
| PQTQALTAPSEAEPG | 56 | A6NGR9 | |
| APLAQPESPTASAGE | 451 | Q8TE49 | |
| SPLAPGPLAQSVDSN | 666 | Q8IWF2 | |
| PGSTASSEPVSPLQE | 846 | A7KAX9 | |
| AAQNPADEPTSGAPA | 906 | Q08379 | |
| PKNTPLSEDDNPGAS | 361 | Q9BT25 | |
| ETPATSAPEAEGPQS | 66 | Q04756 | |
| DDPTAGRSNAPITAP | 406 | Q9Y6M4 | |
| NPPGSPTEEAQPSTS | 421 | P52756 | |
| QTRSEDPQNSAGSPP | 166 | Q8IZQ8 | |
| DPQNSAGSPPDAKAS | 171 | Q8IZQ8 | |
| SPTPNGIPSSDPASD | 11 | Q8NFY9 | |
| EAPPSFSGAQLDSSP | 481 | Q86Y26 | |
| PELGSSENSASSPPR | 1021 | Q9BX63 | |
| SGSDQPSDPLNSPSL | 321 | P53539 | |
| SIPQDLPSAAGSPSA | 101 | Q96BZ4 | |
| QDSSPPGLDLDSSPV | 196 | O00634 | |
| QPSPSHDGSLSPLQD | 126 | Q96A00 | |
| NPPSPENTASSAPVD | 446 | Q5T0Z8 | |
| GTISPSELPDSPGQT | 1191 | O95996 | |
| SNPPAGFPSSRSDAE | 31 | Q14674 | |
| PSLGPSSVASPEDVQ | 631 | Q969S8 | |
| SEPPAASSGPLQDSR | 196 | Q96ID5 | |
| GPDTTPAASDLPTEQ | 551 | P32927 | |
| ISAAQDASAPPAPTG | 36 | Q01094 | |
| HSQGAPNSDPSLEPE | 216 | P55265 | |
| PPSQGDSQSLDIPNT | 456 | P57773 | |
| IEENGPSTGSTPDPT | 381 | Q8WZ74 | |
| EPQSLPPSNLSGSSE | 591 | Q96PV7 | |
| PPSNLSGSSEQQPDI | 596 | Q96PV7 | |
| SSQPQPEGANEAVPT | 256 | P02765 | |
| GTEPSPGQAQDSAPT | 151 | A1L170 | |
| EDGSPPPQARTSSLD | 246 | A1L170 | |
| GSSEPSQPAVQQAPT | 76 | Q8WYQ3 | |
| PATGNVAENSPPGTS | 26 | Q6ZTQ4 | |
| PAPNGTSPLLAAESS | 206 | Q96SL1 | |
| PLGRPSNLPQSSADA | 1176 | O00512 | |
| PALQPSQAAPAEGIS | 216 | Q6RFH8 | |
| PPPAADALQSSGESS | 476 | Q96RY5 | |
| ADESQASVPQPASPL | 551 | A8MPP1 | |
| PPEDSSQDLAPNSVG | 326 | Q86UU0 | |
| ENEQSLPPPAGLNSS | 21 | O60238 | |
| PPPDSKSVSQDSSGQ | 1046 | Q5TEA3 | |
| PNISTSESRSPPEGD | 1031 | Q9BTC0 | |
| SQSSLEGAPATAPEP | 21 | Q9H222 | |
| ADTSNSSNPAPPPGE | 381 | P20908 | |
| GSNSPIPPTQEDTDS | 361 | Q494V2 | |
| PALQPSQAAPAEGVS | 216 | P0CJ90 | |
| PDPAQSGSTPAAEAL | 521 | P98153 | |
| PGEQAQDVASSPPES | 371 | Q9BS26 | |
| PSPESAQSPSPSGDV | 1821 | O15021 | |
| VEPSSGNPSPQQAAS | 1151 | O60336 | |
| EAAASQPQAPTSVPG | 21 | Q9NR33 | |
| QTSQGASDPLPDPLG | 641 | Q08050 | |
| LSSGQPDTQSESPPG | 786 | Q6NY19 | |
| PDTQSESPPGSQTAT | 791 | Q6NY19 | |
| PSQETRTAVGSNPDP | 141 | Q5VTJ3 | |
| SVPPDSQGAQEPAAS | 26 | Q9NQR7 | |
| GTSNPDPPTVSTDQL | 36 | Q99075 | |
| PALQPSQAAPAEGVS | 216 | P0CJ88 | |
| PEPVGTSSNADSASP | 226 | Q8TE68 | |
| PEGLRTPASPSSANA | 391 | O94887 | |
| APEPNSAVPSDGTEA | 116 | Q4VC05 | |
| PGEEPPTSASLTQRQ | 101 | A0A1B0GTI1 | |
| LQGAEEPAAPPTAVS | 226 | Q9NZ56 | |
| GSPEAAETSPPSNII | 621 | Q96T23 | |
| NPNNSSASSEPRPEG | 71 | Q9Y467 | |
| NVPVPTATPGNSEES | 1296 | Q01668 | |
| TPQPTGNSSPTQDDR | 106 | Q8IY42 | |
| STPSAPELGQQPDVN | 701 | Q93100 | |
| PSAAPATRPAGDQQS | 391 | Q8WUT4 | |
| DAATDQGPAESPPTS | 186 | Q8IWE2 | |
| ALDLSSPPATSQSPE | 921 | A6NGG8 | |
| NPEPDASVSSPQAGS | 51 | O14593 | |
| ETDPAPGPLSGQSVN | 876 | Q9Y283 | |
| LTASPQAPGSPEDSE | 1816 | Q5T011 | |
| QGEQSLAPSPSASPV | 731 | Q8N1F8 | |
| EQSSPPSRDPLNNSG | 236 | P58004 | |
| PTQEANGQPSKPDTS | 276 | Q8NC24 | |
| QEPPTTDSQEAQSPG | 151 | Q8NFQ8 | |
| PDAPQLVSSAREGSP | 546 | Q494U1 | |
| LSSPQPASRAPSEEG | 551 | Q96PX1 | |
| SQASQEGSSPEPPPE | 1001 | O75151 | |
| ADSAIESQPSSEGPP | 311 | A5PKW4 | |
| GKSPDPNNPSDLTVT | 876 | Q14DG7 | |
| EQSSPEGASQEPPTA | 571 | A6NKL6 | |
| SPSQEGAPLPSEEAS | 801 | Q6ZMQ8 | |
| TSGPEDQPLTPTGSD | 436 | Q8NHL6 | |
| PDDLNASQSGSSPPQ | 166 | Q8N4C6 | |
| AAGTPENSAPVESEP | 546 | P57071 | |
| PVSSNDTPPSALQEA | 701 | Q7Z3K3 | |
| PGTAQPAAPNTTSPE | 16 | Q99527 | |
| GSSSSQPHPEPEDQV | 891 | O14594 | |
| SDSPAGIDNPVFSPD | 746 | P48764 | |
| ESSPLQEPPSQAAGT | 246 | Q9HAB3 | |
| EGASSPSPKTNNAFP | 576 | Q1XH10 | |
| STAPASREQPAAGPA | 21 | O43272 | |
| AEAPTAPSPAQTLEN | 196 | Q9UHD8 | |
| PTAPAAESAPNGLST | 166 | O15357 | |
| ADSETPLTQDRPGSP | 871 | Q96FS4 | |
| PTGTANDNIPTIDPT | 471 | Q2M3G4 | |
| GDPQQPSPDSTAAQK | 776 | Q9Y6H5 | |
| DGQLTSPATPSPDAS | 226 | Q9NTX7 | |
| DVRAEQPSPPNSDSG | 141 | Q9BUA3 | |
| NTSGSEPVAPNLPSD | 556 | Q8TF30 | |
| NLDPESAPSPPSTQQ | 251 | Q8NE31 | |
| GQSDLTVPNSPPTHD | 181 | Q2KHM9 | |
| PPASALPGSQAADSD | 66 | Q92966 | |
| DLQPPAKPEQGSSAS | 356 | B9A6J9 | |
| TGTSEPPDAQTVAPA | 26 | Q68BL8 | |
| QAEQPSQPSSTPGSE | 6 | O75381 | |
| QQPSGDSNPTLEPSL | 261 | A0A1B0GV85 | |
| EQPASHESQGSVPSP | 126 | Q969V6 | |
| SLSSAEPQPASPQPA | 371 | Q9UPG8 | |
| GENSVPPSPSREQTS | 251 | Q3YBM2 | |
| SAQEGELSLSSPPSP | 896 | Q9NRP7 | |
| QPPTASDGATSRPEL | 111 | O94993 | |
| SEGPSSLDPSQEGPT | 361 | Q13501 | |
| SSQGSSTEAEPPTQP | 1171 | Q9Y566 | |
| PVSPNDSGAKIASNP | 1101 | Q9UK61 | |
| STESSPAPQEGSEQP | 416 | Q66K14 | |
| PAPQEGSEQPASPAS | 421 | Q66K14 | |
| SLAAPDPGQRSSSQP | 301 | Q96AP0 | |
| PGNSSLENLPPVAAS | 701 | P55197 | |
| TQGASSASEPQEAPP | 646 | O96005 | |
| PAPASTSAPGDSLEQ | 751 | Q6ZRI6 | |
| PSILSDPDPDSSNSG | 241 | Q9UKZ1 | |
| APETVQPGATAQPAS | 496 | Q6S5L8 | |
| VAGVVANAPSPPESS | 6 | Q8ND24 | |
| PEPAPTSAGASRAQA | 621 | O15417 | |
| APETSAPVNSGDPTT | 346 | Q9Y2T7 | |
| RGDSASPAPATTPAQ | 871 | Q5T6F2 | |
| SAPAATSQIGFEAPP | 501 | Q9BYV6 | |
| SQGDGRSETSQPPTP | 621 | Q5TCY1 | |
| NDTARPQDIVSSPGP | 561 | P60852 | |
| DQSPSPQDSTGPQLA | 1016 | Q13009 | |
| PQSGSPEPESIRNTS | 1591 | O75970 | |
| SPGASPSQAERLPSD | 736 | Q96T58 | |
| PEESPSEGLNNLSSP | 21 | Q7Z2H8 | |
| SLGEEARDTPQPSSP | 791 | Q8IWN7 | |
| APASSPEAASPTEQG | 1131 | Q92766 | |
| VDVSNEDPSSPRGSP | 256 | Q04727 | |
| DQTPPDGFLSNSDSP | 731 | Q9NXZ1 | |
| PQDSPAGPNLDSTLQ | 226 | Q9UBI4 | |
| QQDPPGPASSSAPTL | 481 | A6NFA1 | |
| ELPPQTASEAPSEGS | 801 | Q5TCZ1 | |
| PEPPGSASSSSQESL | 1341 | Q9P227 | |
| GSPETSRSLPAPQDN | 356 | O43353 | |
| DATNPPEGPQDRSSQ | 26 | O76061 | |
| TSPTGQQPSDAFPED | 406 | P42331 | |
| NSPGSDTPRSVASPE | 16 | A6NJL1 | |
| GAEQPPSPASTSSQE | 21 | Q99469 | |
| PSVAAAAGPAPQSLD | 496 | Q7L0X0 | |
| PDAQPGEAAESSPSF | 91 | A0A1W2PR48 | |
| DIDASSPPSGSIPSQ | 471 | Q9UHP3 | |
| PESSALQPPPQSSEG | 451 | P42768 | |
| NPTPENGEAPASTSP | 336 | P28908 | |
| SPSAEKASPQENGPA | 556 | Q5JSZ5 | |
| LGPSPEPAASSQQAE | 31 | Q86WS5 | |
| SSPPSSQAPGALQEC | 571 | P78364 | |
| ASPGVTPTQDAPETE | 1066 | O95359 | |
| QGPSSEETPPQTKSA | 536 | O43566 | |
| GSQEDDPAATQRPPS | 626 | Q9UGU0 | |
| DAAVPAQDPSNSDPG | 801 | Q92543 | |
| AQTLPPPTAAGESNS | 796 | Q13472 | |
| NVDGQEVAPSSPPLA | 171 | Q9NWS9 | |
| ANPSSEESQLPGPLG | 616 | Q96JG9 | |
| SSGSEEEPAPSSLQP | 116 | F5GYI3 | |
| QTGSAQEDSPHPSSP | 706 | O15090 | |
| DASQPTSQDSPLPPS | 46 | P58753 | |
| STDALTDPVTDPGPN | 631 | Q8N398 | |
| PNDSLPSPSTIVSGD | 1081 | Q7Z7G8 | |
| SQAEATLPGPTEAPN | 1571 | Q92508 | |
| AERQSTPPGDSSSLP | 11 | Q8N3L3 | |
| LELPTSGDPPASASQ | 11 | Q9NV72 | |
| TPQTQPDVSPLSNGD | 1061 | P52746 | |
| VPNGPSSPTNESAPE | 261 | Q8TF74 | |
| PPSPTSGESGDLLSN | 206 | Q96QU8 | |
| QPGSPSLVSEESPSA | 766 | P31629 | |
| QATDEPPASQGSKPA | 571 | O15016 | |
| SSQSGQSPPEPQDPE | 376 | Q9H4Z2 | |
| GPQQDLPPEASAASS | 36 | Q9H4I2 | |
| QSNVAAPGDATPPAE | 246 | Q96QC0 | |
| PESVPPGSLSNVSDN | 1141 | Q6BDS2 | |
| GDSSESAASQPPTPR | 476 | O14939 | |
| QGTASALSQSQEPPP | 361 | Q9H347 | |
| SSQEPGSGQPLPEES | 386 | Q9H347 | |
| SQDPPALARSTPGSN | 231 | O15231 | |
| PSTPEQQNSPSGSEQ | 511 | O15231 | |
| ETPAAQSPTRGPSDT | 271 | P53814 | |
| SSPQPGASDTAVPEQ | 276 | Q96H15 | |
| SQLHPGDTDSVQPSP | 156 | Q6SJ96 | |
| GDTDSVQPSPEKPNS | 161 | Q6SJ96 | |
| FQSEEVSPAEPASPG | 91 | Q9H808 | |
| ASSPAPEENAPSEGQ | 231 | P78423 | |
| TAPNSRAAENGAPDP | 351 | Q9H0D2 | |
| PALQPSQAAPAEGVS | 216 | P0CJ85 | |
| SSATALQIQPPGSPD | 761 | Q9P206 |